DE280853C
(lt)
|
|
|
|
|
US850370A
(en)
|
1906-06-05 |
1907-04-16 |
William L Hynes |
Water-automobile.
|
DE2156720A1
(de)
|
1971-11-16 |
1973-05-24 |
Bayer Ag |
Pyrimido eckige klammer auf 4,5-d eckige klammer zu pyrimidine
|
US3984021A
(en)
|
1972-09-11 |
1976-10-05 |
Uhlig Gerhardt E |
Safety closure container
|
US3894021A
(en)
|
1974-01-28 |
1975-07-08 |
Squibb & Sons Inc |
Derivatives of 1,7-dihydro-2H-pyrazolo{8 4{40 ,3{40 :5,6{9 pyrido{8 4,3-D{9 pyrimidine-2,4-(3H)-diones
|
JPS5120580B2
(lt)
|
1974-06-19 |
1976-06-25 |
|
|
US4347348A
(en)
|
1978-06-05 |
1982-08-31 |
Chernikhov Alexei Y |
Heat-resistant heterocyclic polymers and methods for producing same
|
FR2428654A1
(fr)
|
1978-06-13 |
1980-01-11 |
Chernikhov Alexei |
Polymeres heterocycliques thermostables et leurs procedes de preparation
|
CH635828A5
(de)
|
1978-08-30 |
1983-04-29 |
Ciba Geigy Ag |
N-substituierte imide und bisimide.
|
CH641470A5
(de)
|
1978-08-30 |
1984-02-29 |
Ciba Geigy Ag |
Imidgruppen enthaltende silane.
|
US4339267A
(en)
|
1980-01-18 |
1982-07-13 |
E. I. Du Pont De Nemours And Company |
Herbicidal sulfonamides
|
US4405786A
(en)
|
1980-10-22 |
1983-09-20 |
Plastics Engineering Company |
Addition products of di-acetylene-terminated polyimide derivatives and an dienophile having ethylene groups
|
US4405520A
(en)
|
1980-10-22 |
1983-09-20 |
Plastics Engineering Company |
Addition products of di-acetylene-terminated polymide derivatives and dienophiles having terminal maleimide grops
|
US4405519A
(en)
|
1980-10-22 |
1983-09-20 |
Plastics Engineering Company |
Di-Acetylene-terminated polyimide derivatives
|
US4402878A
(en)
|
1980-10-22 |
1983-09-06 |
Plastics Engineering Company |
Addition products of di-acetylene-terminated polyimide derivatives with a polyimide having terminal non-conjugated acetylene groups
|
US4460773A
(en)
|
1982-02-05 |
1984-07-17 |
Lion Corporation |
1-Phenyl-1H-pyrazolo [3,4-b]pyrazine derivatives and process for preparing same
|
DE3432983A1
(de)
|
1983-09-07 |
1985-04-18 |
Lion Corp., Tokio/Tokyo |
1,5-disubstituierte 1h-pyrazolo(3,4-b)-pyrazin-derivate und antitumormittel, die diese enthalten
|
JPS62273979A
(ja)
|
1986-05-21 |
1987-11-28 |
Lion Corp |
1,5−置換−1H−ピラゾロ〔3,4−b〕ピラジン誘導体及び該化合物を含有する抗腫瘍剤
|
JPS6310630A
(ja)
|
1986-06-23 |
1988-01-18 |
Teijin Ltd |
芳香族ポリアミドイミドエ−テルの製造法
|
JPS6317882A
(ja)
|
1986-07-09 |
1988-01-25 |
Lion Corp |
5−置換−1H−ピラゾロ〔3,4−b〕ピラジン誘導体及び該化合物を含有する抗腫瘍剤
|
US4859672A
(en)
|
1986-10-29 |
1989-08-22 |
Rorer Pharmaceutical Corporation |
Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone
|
US4874803A
(en)
|
1987-09-21 |
1989-10-17 |
Pennwalt Corporation |
Dianhydride coupled polymer stabilizers
|
DE3814549A1
(de)
|
1987-10-30 |
1989-05-18 |
Bayer Ag |
N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln
|
JPH029895A
(ja)
|
1988-06-28 |
1990-01-12 |
Lion Corp |
ヌクレオシド類似化合物及び抗腫瘍剤
|
DD280853A1
(de)
|
1989-03-21 |
1990-07-18 |
Akad Nauk Sssr |
Bindemittel fuer elektroden, vorzugsweise fuer polymerelektroden
|
US5159054A
(en)
|
1989-05-16 |
1992-10-27 |
The United States Of America As Represented By The Secretary Of The Navy |
Synthesis of phthalonitrile resins containing ether and imide linkages
|
JP2845957B2
(ja)
|
1989-07-17 |
1999-01-13 |
三井化学株式会社 |
イミド環を有する新規ジフェノール類およびその製造方法
|
US5726302A
(en)
|
1989-09-15 |
1998-03-10 |
Gensia Inc. |
Water soluble adenosine kinase inhibitors
|
DE3937633A1
(de)
|
1989-11-11 |
1991-05-16 |
Bayer Ag |
Heterocyclische verbindungen und deren verwendung als pigmente und farbstoffe
|
DE59009701D1
(de)
|
1989-12-28 |
1995-10-26 |
Hoechst Ag |
Biskationische säureamid- und -imidderivate als ladungssteuermittel.
|
CA2072597C
(en)
|
1989-12-28 |
1998-09-22 |
Hans-Tobias Macholdt |
Biscationic acid amide and imide derivatives and processes for their preparation
|
JP2883670B2
(ja)
|
1990-03-23 |
1999-04-19 |
三井化学株式会社 |
イミド環を有する新規ビスフェノール類およびその製造方法
|
GB9113137D0
(en)
|
1990-07-13 |
1991-08-07 |
Ici Plc |
Thioxo heterocycles
|
ATE175665T1
(de)
|
1990-10-03 |
1999-01-15 |
Commw Scient Ind Res Org |
Epoxydharze auf basis von diaminobisimidverbindungen
|
JPH04158084A
(ja)
|
1990-10-22 |
1992-06-01 |
Fuji Photo Film Co Ltd |
記録材料
|
JPH04179576A
(ja)
|
1990-11-14 |
1992-06-26 |
Fuji Photo Film Co Ltd |
記録材料
|
JPH04328121A
(ja)
|
1991-04-26 |
1992-11-17 |
Sumitomo Bakelite Co Ltd |
半導体封止用エポキシ樹脂組成物
|
EP0590022A1
(en)
|
1991-06-14 |
1994-04-06 |
PHARMACIA & UPJOHN COMPANY |
IMIDAZO 1,5-a]QUINOXALINES
|
DE4119767A1
(de)
|
1991-06-15 |
1992-12-17 |
Dresden Arzneimittel |
Verfahren zur herstellung von (pyrimid-2-yl-thio- bzw. seleno)-essigsaeurederivaten
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
JP3279635B2
(ja)
|
1992-05-18 |
2002-04-30 |
鐘淵化学工業株式会社 |
ヒドロシリル基含有イミド化合物
|
JP3232123B2
(ja)
|
1992-05-20 |
2001-11-26 |
鐘淵化学工業株式会社 |
硬化性組成物
|
CA2136606A1
(en)
|
1992-05-28 |
1993-11-29 |
Trevor C. Morton |
Bismaleimide compounds
|
CA2150566A1
(en)
|
1992-12-07 |
1994-06-23 |
Jonathan Howard Hodgkin |
Bisnadimides
|
JPH08506189A
(ja)
|
1993-01-11 |
1996-07-02 |
ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア |
非線形光学的性質を有する多環式芳香族化合物
|
WO1994025438A1
(en)
|
1993-04-28 |
1994-11-10 |
The Du Pont Merck Pharmaceutical Company |
Novel trisubstituted aromatic amines useful for the treatment of cognitive deficits
|
US5536725A
(en)
|
1993-08-25 |
1996-07-16 |
Fmc Corporation |
Insecticidal substituted-2,4-diamino-5,6,7,8-tetrahydroquinazolines
|
DE10075033I2
(de)
|
1993-11-30 |
2001-08-02 |
Searle & Co |
substituierte Pyrazolyl-benzolsulfonamide zur Behandlung von Entzündungen.
|
US5480887A
(en)
|
1994-02-02 |
1996-01-02 |
Eli Lilly And Company |
Protease inhibitors
|
CA2182090A1
(en)
|
1994-02-02 |
1995-08-10 |
William Joseph Hornback |
Hiv protease inhibitors and intermediates
|
EP0790997B1
(en)
|
1994-11-14 |
2000-03-22 |
Warner-Lambert Company |
6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
|
US7067664B1
(en)
|
1995-06-06 |
2006-06-27 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
US5783577A
(en)
|
1995-09-15 |
1998-07-21 |
Trega Biosciences, Inc. |
Synthesis of quinazolinone libraries and derivatives thereof
|
JPH09188812A
(ja)
|
1996-01-11 |
1997-07-22 |
Mitsui Toatsu Chem Inc |
結晶化促進剤
|
AU2980797A
(en)
|
1996-06-11 |
1998-01-07 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Fused heterocyclic compounds and medicinal uses thereof
|
DE69719193T2
(de)
|
1996-08-06 |
2003-09-25 |
Pfizer |
Substituierte pyrido- oder pyrimidogruppen enthaltende 6,6- oder 6,7-bicyclische derivate
|
AU4054197A
(en)
|
1996-08-14 |
1998-03-06 |
Warner-Lambert Company |
2-phenyl benzimidazole derivatives as mcp-1 antagonists
|
JP3669783B2
(ja)
|
1996-08-21 |
2005-07-13 |
三井化学株式会社 |
有機電界発光素子
|
US5994364A
(en)
|
1996-09-13 |
1999-11-30 |
Schering Corporation |
Tricyclic antitumor farnesyl protein transferase inhibitors
|
WO1998018781A2
(en)
|
1996-10-28 |
1998-05-07 |
Versicor, Inc. |
Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents
|
EP0946523A1
(en)
|
1996-12-23 |
1999-10-06 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
|
WO1998033798A2
(en)
|
1997-02-05 |
1998-08-06 |
Warner Lambert Company |
Pyrido[2,3-d]pyrimidines and 4-amino-pyrimidines as inhibitors of cell proliferation
|
EP0973777A1
(en)
|
1997-04-11 |
2000-01-26 |
Abbott Laboratories |
Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
|
AU747026B2
(en)
|
1997-05-28 |
2002-05-09 |
Aventis Pharmaceuticals Inc. |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
|
GB9716231D0
(en)
|
1997-07-31 |
1997-10-08 |
Amersham Int Ltd |
Base analogues
|
EP0994892A1
(en)
|
1997-08-11 |
2000-04-26 |
Cor Therapeutics, Inc. |
SELECTIVE FACTOR Xa INHIBITORS
|
WO1999009030A1
(en)
|
1997-08-20 |
1999-02-25 |
Warner-Lambert Company |
Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
|
US6465484B1
(en)
|
1997-09-26 |
2002-10-15 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
JPH11171865A
(ja)
|
1997-12-04 |
1999-06-29 |
Yoshitomi Pharmaceut Ind Ltd |
縮合ヘテロ環化合物
|
US6350749B1
(en)
|
1998-02-20 |
2002-02-26 |
Takeda Chemical Industries, Ltd. |
Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof
|
EP1077946A1
(en)
|
1998-05-15 |
2001-02-28 |
Guilford Pharmaceuticals Inc. |
Fused tricyclic compounds which inhibit parp activity
|
ES2310039T3
(es)
|
1998-05-26 |
2008-12-16 |
Warner-Lambert Company Llc |
Pirimidinas biciclicas y 3,4-dihidropirimidinas biciclicas como inhibidores de la proliferacion celular.
|
US20040044012A1
(en)
|
1998-05-26 |
2004-03-04 |
Dobrusin Ellen Myra |
Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
|
JP2002517486A
(ja)
|
1998-06-12 |
2002-06-18 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
p38のインヒビター
|
CN1152031C
(zh)
|
1998-08-11 |
2004-06-02 |
诺瓦提斯公司 |
具有血管生成抑制活性的异喹啉衍生物
|
JP2000123973A
(ja)
|
1998-10-09 |
2000-04-28 |
Canon Inc |
有機発光素子
|
GB9823103D0
(en)
|
1998-10-23 |
1998-12-16 |
Pfizer Ltd |
Pharmaceutically active compounds
|
ID28276A
(id)
|
1998-10-23 |
2001-05-10 |
Hoffmann La Roche |
Heterolingkar nitrogen bisiklik
|
US6133031A
(en)
|
1999-08-19 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of focal adhesion kinase expression
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
DE19912638A1
(de)
|
1999-03-20 |
2000-09-21 |
Bayer Ag |
Naphthylcarbonsäureamid-substituierte Sulfonamide
|
DE19920790A1
(de)
|
1999-05-06 |
2000-11-09 |
Bayer Ag |
Bis-Sulfonamide mit anti-HCMV-Wirkung
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
JP4041624B2
(ja)
|
1999-07-21 |
2008-01-30 |
三井化学株式会社 |
有機電界発光素子
|
EA005423B1
(ru)
|
1999-09-24 |
2005-02-24 |
Янссен Фармацевтика Н.В. |
Противовирусные композиции
|
DE19946289A1
(de)
|
1999-09-28 |
2001-03-29 |
Basf Ag |
Benzodiazepin-Derivate, deren Herstellung und Anwendung
|
MXPA02003841A
(es)
|
1999-10-21 |
2002-09-30 |
Hoffmann La Roche |
Heterociclos de nitrogeno biciclicos alquilamino substituidos como inhibidores de proteina p38.
|
JP3961830B2
(ja)
|
1999-10-21 |
2007-08-22 |
エフ.ホフマン−ラ ロシュ アーゲー |
p38プロテインキナーゼのインヒビターとしてのヘテロアルキルアミノ置換二環式窒素複素環
|
TWI271406B
(en)
|
1999-12-13 |
2007-01-21 |
Eisai Co Ltd |
Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
|
DK1242382T3
(da)
|
1999-12-29 |
2007-05-07 |
Wyeth Corp |
Tricycliske proteinkinaseinhibitorer
|
BR0017010A
(pt)
|
2000-01-24 |
2002-11-05 |
Warner Lambert Co |
Agentes antibacterianos 3-aminoquinazolin-2,4-diona
|
US20040224958A1
(en)
|
2000-01-27 |
2004-11-11 |
Booth Richard John |
Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
|
AU2001240542A1
(en)
|
2000-02-01 |
2001-08-14 |
Basf Aktiengesellschaft |
Heterocyclic compounds and their use as parp inhibitors
|
DK1257550T3
(da)
|
2000-02-04 |
2006-03-27 |
Portola Pharm Inc |
Blodplade-ADP-receptor-inhibitor
|
AU2001231710A1
(en)
|
2000-02-09 |
2001-08-20 |
Novartis Ag |
Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
AU2001235804A1
(en)
|
2000-03-06 |
2001-09-17 |
Astrazeneca Ab |
Therapy
|
DE10012549A1
(de)
|
2000-03-15 |
2001-09-20 |
Bayer Ag |
Arzneimittel gegen virale Erkrankungen
|
JP2001265031A
(ja)
|
2000-03-15 |
2001-09-28 |
Fuji Xerox Co Ltd |
電子写真感光体、プロセスカートリッジ、及び、電子写真装置
|
BR0110420A
(pt)
|
2000-04-28 |
2003-07-01 |
Acadia Pharm Inc |
Agonistas muscarìnicos
|
CA2408156A1
(en)
|
2000-05-05 |
2001-11-15 |
Millennium Pharmaceuticals, Inc. |
Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
|
NZ523184A
(en)
|
2000-06-23 |
2004-06-25 |
Bristol Myers Squibb Pharma Co |
1 - (heteroaryl-phenyl) - condensed pyrazol derivatives as factor Xa inhibitors
|
CA2413330A1
(en)
|
2000-06-28 |
2002-01-03 |
Smithkline Beecham P.L.C. |
Wet milling process
|
US20050009876A1
(en)
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
WO2002012442A2
(en)
|
2000-08-07 |
2002-02-14 |
Neurogen Corporation |
Heterocyclic compounds as ligands of the gabaa receptor
|
DK1309593T3
(da)
|
2000-08-14 |
2006-07-17 |
Ortho Mcneil Pharm Inc |
Substituerede pyrazoler
|
CN1212839C
(zh)
|
2000-09-06 |
2005-08-03 |
奥索-麦克尼尔药品公司 |
取代的吡唑在制备用于治疗变态反应的药物方面的用途
|
GB0025782D0
(en)
|
2000-10-20 |
2000-12-06 |
Pfizer Ltd |
Use of inhibitors
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
GB0100621D0
(en)
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical compounds VI
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
WO2002076953A1
(en)
|
2001-03-21 |
2002-10-03 |
Warner-Lambert Company Llc |
New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
|
US6998408B2
(en)
|
2001-03-23 |
2006-02-14 |
Bristol-Myers Squibb Pharma Company |
6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors
|
JP2002296731A
(ja)
|
2001-03-30 |
2002-10-09 |
Fuji Photo Film Co Ltd |
熱現像カラー画像記録材料
|
JP4535680B2
(ja)
|
2001-04-16 |
2010-09-01 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
新規1h−インダゾール化合物
|
EP1382603B1
(en)
|
2001-04-26 |
2008-07-23 |
Eisai R&D Management Co., Ltd. |
Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
|
WO2002088095A1
(en)
|
2001-04-30 |
2002-11-07 |
Glaxo Group Limited |
Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
|
WO2002094825A1
(fr)
|
2001-05-22 |
2002-11-28 |
Banyu Pharmaceutical Co., Ltd. |
Nouveau derive de spiropiperidine
|
US20030114448A1
(en)
|
2001-05-31 |
2003-06-19 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
AU2002302894A1
(en)
|
2001-06-19 |
2003-01-02 |
Warner-Lambert Company Llc |
Quinazolinediones as antibacterial agents
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
AU2002315389A1
(en)
|
2001-06-21 |
2003-01-08 |
Ariad Pharmaceuticals, Inc. |
Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
|
WO2003000690A1
(en)
|
2001-06-25 |
2003-01-03 |
Aventis Pharmaceuticals Inc. |
Synthesis of heterocyclic compounds employing microwave technology
|
WO2003009852A1
(en)
|
2001-07-24 |
2003-02-06 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
HUP0401108A2
(hu)
|
2001-08-07 |
2004-09-28 |
Banyu Pharmaceutical Co., Ltd. |
Spirovegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
|
AU2002337142B2
(en)
|
2001-09-19 |
2007-10-11 |
Aventis Pharma S.A. |
Indolizines as kinase protein inhibitors
|
CA2462657C
(en)
|
2001-10-30 |
2011-04-26 |
Novartis Ag |
Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
|
EP1448556A1
(en)
|
2001-11-01 |
2004-08-25 |
Janssen Pharmaceutica N.V. |
Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
|
EP1444223A1
(en)
|
2001-11-07 |
2004-08-11 |
F. Hoffmann-La Roche Ag |
Aminopyrimidines and -pyridines
|
JP4488740B2
(ja)
|
2001-11-13 |
2010-06-23 |
ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド |
免疫細胞活性化を調節する作用剤およびその使用方法
|
GB0129476D0
(en)
|
2001-12-10 |
2002-01-30 |
Syngenta Participations Ag |
Organic compounds
|
IL162721A0
(en)
|
2002-01-22 |
2005-11-20 |
Warner Lambert Co |
2-(Pyridin-2-ylamino)-pyridoÄ2,3-dÜpyrimidin-7-ones
|
NZ534583A
(en)
|
2002-03-05 |
2006-11-30 |
Axys Pharm Inc |
Leucinamide derivatives suitable as cathepsin cysteine protease inhibitors
|
US6815519B2
(en)
|
2002-03-22 |
2004-11-09 |
Chung-Shan Institute Of Science & Technology |
Acidic fluorine-containing poly (siloxane amideimide) silica hybrids
|
AU2003215675B2
(en)
|
2002-04-03 |
2007-07-12 |
F. Hoffmann-La Roche Ag |
Imidazo fused compounds
|
JP2006502097A
(ja)
|
2002-05-15 |
2006-01-19 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Pdgf受容体阻害剤としてのn−置換三環状3−アミノピラゾール
|
JP4499342B2
(ja)
|
2002-05-16 |
2010-07-07 |
株式会社カネカ |
SiH基を含有する含窒素有機系化合物の製造方法
|
ATE478867T1
(de)
|
2002-05-23 |
2010-09-15 |
Novartis Vaccines & Diagnostic |
Substituierte quinazolinone verbindungen
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
US7119111B2
(en)
|
2002-05-29 |
2006-10-10 |
Amgen, Inc. |
2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
US7196090B2
(en)
|
2002-07-25 |
2007-03-27 |
Warner-Lambert Company |
Kinase inhibitors
|
IL166241A
(en)
|
2002-07-29 |
2011-12-29 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds for use in the treatment of autoimmune diseases
|
CA2492112A1
(en)
|
2002-08-06 |
2004-02-19 |
F. Hoffmann-La Roche Ag |
6-alkoxy-pyrido-pyrimidines as p-38 map kinase inhibitors
|
EP1388541A1
(en)
|
2002-08-09 |
2004-02-11 |
Centre National De La Recherche Scientifique (Cnrs) |
Pyrrolopyrazines as kinase inhibitors
|
US7084270B2
(en)
|
2002-08-14 |
2006-08-01 |
Hoffman-La Roche Inc. |
Pyrimido compounds having antiproliferative activity
|
GB0220187D0
(en)
|
2002-08-30 |
2002-10-09 |
Novartis Ag |
Organic compounds
|
GB0223349D0
(en)
|
2002-10-08 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
TW200413381A
(en)
|
2002-11-04 |
2004-08-01 |
Hoffmann La Roche |
Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
|
US7129351B2
(en)
|
2002-11-04 |
2006-10-31 |
Hoffmann-La Roche Inc. |
Pyrimido compounds having antiproliferative activity
|
WO2004043367A2
(en)
|
2002-11-06 |
2004-05-27 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds and use thereof
|
TWI335913B
(en)
|
2002-11-15 |
2011-01-11 |
Vertex Pharma |
Diaminotriazoles useful as inhibitors of protein kinases
|
DE60327097D1
(de)
|
2002-11-18 |
2009-05-20 |
Hoffmann La Roche |
Diazinopyrimidine und ihre verwendung als proteinkinaseinhibitoren
|
CN1717396A
(zh)
|
2002-11-28 |
2006-01-04 |
舍林股份公司 |
Chk-、Pdk-和Akt-抑制嘧啶,其制备及作为药物的用途
|
JP4903385B2
(ja)
|
2002-12-06 |
2012-03-28 |
パーデュー・リサーチ・ファウンデーション |
損傷した哺乳類神経組織を治療するためのピリジン類
|
US7759336B2
(en)
|
2002-12-10 |
2010-07-20 |
Ono Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compounds and medicinal use thereof
|
UA80171C2
(en)
|
2002-12-19 |
2007-08-27 |
Pfizer Prod Inc |
Pyrrolopyrimidine derivatives
|
US7098332B2
(en)
|
2002-12-20 |
2006-08-29 |
Hoffmann-La Roche Inc. |
5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
CA2508660C
(en)
|
2002-12-23 |
2013-08-20 |
Wyeth |
Antibodies against pd-1 and uses therefor
|
JP2004203749A
(ja)
|
2002-12-24 |
2004-07-22 |
Kanegafuchi Chem Ind Co Ltd |
SiH基を含有する含窒素有機系化合物の製造方法
|
JP2006516561A
(ja)
|
2003-01-17 |
2006-07-06 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
細胞増殖の阻害剤としての2−アミノピリジン置換ヘテロ環類
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
US7135469B2
(en)
|
2003-03-18 |
2006-11-14 |
Bristol Myers Squibb, Co. |
Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
|
US20040242566A1
(en)
|
2003-03-25 |
2004-12-02 |
Syrrx, Inc. |
Dipeptidyl peptidase inhibitors
|
GB0308208D0
(en)
|
2003-04-09 |
2003-05-14 |
Glaxo Group Ltd |
Chemical compounds
|
BRPI0409366A
(pt)
|
2003-04-10 |
2006-04-25 |
Hoffmann La Roche |
compostos de pirimido
|
CN100372851C
(zh)
|
2003-05-05 |
2008-03-05 |
弗·哈夫曼-拉罗切有限公司 |
具有crf活性的稠合的嘧啶衍生物
|
JP2004346145A
(ja)
|
2003-05-21 |
2004-12-09 |
Teijin Ltd |
イミド組成物およびそれからなる樹脂組成物、及びその製造方法
|
AU2004249120B2
(en)
|
2003-05-23 |
2008-07-24 |
Glaxosmithkline |
Guanidino-substituted quinazolinone compounds as MC4-R agonists
|
KR101205257B1
(ko)
|
2003-06-06 |
2012-11-27 |
아렉시스 악티에볼라그 |
피부 상태 또는 암 치료를 위한 scce 저해제로서의 융합된 헤테로사이클 화합물의 용도
|
IL156495A0
(en)
|
2003-06-17 |
2004-01-04 |
Prochon Biotech Ltd |
Use of fgfr3 antagonists for treating t cell mediated diseases
|
WO2004113307A1
(ja)
|
2003-06-18 |
2004-12-29 |
Ube Industries, Ltd. |
ピリミジン−4−オン化合物の製造方法
|
JP2005015395A
(ja)
|
2003-06-26 |
2005-01-20 |
Japan Science & Technology Agency |
新規ピリミドピリミジンヌクレオシドとその構造類縁体
|
CA2531327A1
(en)
|
2003-07-03 |
2005-01-13 |
Myriad Genetics, Inc. |
Compounds and therapeutical use thereof
|
AR045037A1
(es)
|
2003-07-10 |
2005-10-12 |
Aventis Pharma Sa |
Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion.
|
CA2533774A1
(en)
|
2003-07-29 |
2005-02-10 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
US7390820B2
(en)
|
2003-08-25 |
2008-06-24 |
Amgen Inc. |
Substituted quinolinone derivatives and methods of use
|
AU2004274403A1
(en)
|
2003-09-03 |
2005-03-31 |
Aventis Pharmaceuticals Inc. |
5-aryl-Pyrazolo(4,3-d)pyrimidines, pyridines, and pyrazines and related compounds
|
CN101906106A
(zh)
|
2003-09-18 |
2010-12-08 |
康福玛医药公司 |
作为hsp90-抑制剂的新的杂环化合物
|
EP1664046B1
(en)
|
2003-09-19 |
2009-06-17 |
Gilead Sciences, Inc. |
Aza-quinolinol phosphonate integrase inhibitor compounds
|
PE20050952A1
(es)
|
2003-09-24 |
2005-12-19 |
Novartis Ag |
Derivados de isoquinolina como inhibidores de b-raf
|
CA2540647C
(en)
|
2003-10-01 |
2012-07-10 |
Bayer Healthcare Ag |
Tetrahydro-naphthalene and urea derivatives
|
CN1863774B
(zh)
*
|
2003-10-08 |
2010-12-15 |
Irm责任有限公司 |
用作蛋白激酶抑制剂的化合物和组合物
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
US20090099165A1
(en)
|
2003-10-14 |
2009-04-16 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Protein Kinase Inhibitors
|
EP1687309A1
(en)
|
2003-11-17 |
2006-08-09 |
Pfizer Products Inc. |
Pyrrolopyrimidine compounds useful in treatment of cancer
|
WO2005056524A2
(en)
|
2003-12-09 |
2005-06-23 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
US20080188527A1
(en)
|
2003-12-23 |
2008-08-07 |
Cashman John R |
Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer
|
KR100703068B1
(ko)
|
2003-12-30 |
2007-04-05 |
에스케이케미칼주식회사 |
피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물
|
US20050222171A1
(en)
|
2004-01-22 |
2005-10-06 |
Guido Bold |
Organic compounds
|
US7902225B2
(en)
|
2004-01-23 |
2011-03-08 |
Janssen Pharmaceutica Nv |
Mycobacterial inhibitors
|
CA2553969A1
(en)
|
2004-01-23 |
2005-08-04 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
EP1715855A4
(en)
|
2004-01-29 |
2010-06-16 |
Elixir Pharmaceuticals Inc |
ANTIVIRAL DRUGS
|
GB0402137D0
(en)
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|
PT1713806E
(pt)
|
2004-02-14 |
2013-08-27 |
Irm Llc |
Compostos e composições como inibidores da proteína quinase
|
JP2007523151A
(ja)
|
2004-02-18 |
2007-08-16 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
2−(ピリジン−3−イルアミノ)−ピリド[2,3−d]ピリミジン−7−オン
|
RU2006134021A
(ru)
|
2004-02-27 |
2008-04-10 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
Производные гетероарил-конденсированного пиразола
|
KR100843526B1
(ko)
|
2004-02-27 |
2008-07-03 |
에프. 호프만-라 로슈 아게 |
피라졸의 접합 유도체
|
WO2005087765A1
(en)
|
2004-03-04 |
2005-09-22 |
Arena Pharmaceuticals, Inc. |
Ligands of follicle stimulating hormone receptor and methods of use thereof
|
JPWO2005085210A1
(ja)
|
2004-03-10 |
2008-01-17 |
小野薬品工業株式会社 |
ニトリル化合物およびその化合物を有効成分として含有する医薬組成物
|
KR100861434B1
(ko)
|
2004-03-29 |
2008-10-02 |
미쓰이 가가쿠 가부시키가이샤 |
신규 화합물 및 그 화합물을 사용한 유기 엘렉트로닉스소자
|
WO2005105097A2
(en)
*
|
2004-04-28 |
2005-11-10 |
Gpc Biotech Ag |
Pyridopyrimidines for treating inflammatory and other diseases
|
JP2005320288A
(ja)
|
2004-05-10 |
2005-11-17 |
Mitsui Chemicals Inc |
テトラカルボン酸誘導体、および該化合物を用いた電子写真感光体、電子写真装置
|
US20050256309A1
(en)
|
2004-05-12 |
2005-11-17 |
Altenbach Robert J |
Tri-and bi-cyclic heteroaryl histamine-3 receptor ligands
|
JP4842929B2
(ja)
|
2004-05-27 |
2011-12-21 |
ファイザー・プロダクツ・インク |
癌治療に有用なピロロピリミジン誘導体
|
WO2005118587A1
(en)
|
2004-06-02 |
2005-12-15 |
Takeda Pharmaceutical Company Limited |
Indole derivative and use for treatment of cancer
|
PE20060426A1
(es)
|
2004-06-02 |
2006-06-28 |
Schering Corp |
DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa
|
MXPA06014247A
(es)
|
2004-06-10 |
2007-03-12 |
Irm Llc |
Compuestos y composiciones como inhibidores de la proteina quinasa.
|
PT1761528E
(pt)
|
2004-06-11 |
2008-04-15 |
Japan Tobacco Inc |
Derivados de 5-amino-2,4,7-trioxo-3,4,7,8-tetra-hidro-2hpirido[ 2,3-d]pirimidina e compostos relacionados para o tratamento do cancro
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
JP2006028027A
(ja)
|
2004-07-12 |
2006-02-02 |
Mitsui Chemicals Inc |
テトラカルボン酸誘導体、および該化合物を用いた電子写真感光体、電子写真装置
|
EP1789417A1
(en)
|
2004-08-31 |
2007-05-30 |
F.Hoffmann-La Roche Ag |
AMIDE DERIVATIVES OF 7-AMINO-3-PHENYL-DIHYDROPYRIMIDO [4,5-d]PYRIMIDINONES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS
|
WO2006024834A1
(en)
|
2004-08-31 |
2006-03-09 |
Astrazeneca Ab |
Quinazolinone derivatives and their use as b-raf inhibitors
|
CA2576818A1
(en)
|
2004-08-31 |
2006-03-09 |
F. Hoffmann-La Roche Ag |
Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
|
DE102004042667A1
(de)
|
2004-09-01 |
2006-03-30 |
Ewald Dörken Ag |
Mehrschichtige Gebäudewand
|
US7687113B2
(en)
|
2004-09-10 |
2010-03-30 |
Ube Industries, Inc. |
Modified polyimide resin and curable resin composition
|
WO2007053135A1
(en)
|
2004-09-14 |
2007-05-10 |
Minerva Biotechnologies Corporation |
Methods for diagnosis and treatment of cancer
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
WO2006038112A1
(en)
|
2004-10-01 |
2006-04-13 |
Warner-Lambert Company Llc |
Use of kinase inhibitors to promote neochondrogenesis
|
FR2876582B1
(fr)
|
2004-10-15 |
2007-01-05 |
Centre Nat Rech Scient Cnrse |
Utilisation de derives de pyrrolo-pyrazines pour la fabrication de medicaments pour le traitement de la mucoviscidose et de maladies liees a un defaut d'adressage des proteines dans les cellules
|
WO2006050162A2
(en)
|
2004-10-28 |
2006-05-11 |
Phenomix Corporation |
Imidazole derivatives
|
WO2006050076A1
(en)
|
2004-10-29 |
2006-05-11 |
Janssen Pharmaceutica, N.V. |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
MX2007005434A
(es)
|
2004-11-08 |
2007-07-10 |
Baxter Int |
Composiciones de nanoparticulado de inhibidor de tubulina.
|
MX2007005820A
(es)
|
2004-11-18 |
2007-07-18 |
Incyte Corp |
Inhibidores de deshidrogenasa esteroide hidroxilo 11-beta tipo 1 y metodos de uso de los mismos.
|
US7795259B2
(en)
|
2004-11-22 |
2010-09-14 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
CN101106983A
(zh)
|
2004-11-24 |
2008-01-16 |
诺瓦提斯公司 |
JAK抑制剂与至少一种Bcr-Abl、Flt-3、FAK或RAF激酶抑制剂的组合
|
MY140748A
(en)
|
2004-12-06 |
2010-01-15 |
Astrazeneca Ab |
Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
|
WO2006065703A1
(en)
|
2004-12-13 |
2006-06-22 |
Sunesis Pharmaceuticals, Inc. |
Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors
|
US20100152206A1
(en)
|
2005-01-07 |
2010-06-17 |
Ralph Mazitschek |
Bicyclic Dihydropyrimidines and Uses Thereof
|
DE102005008310A1
(de)
|
2005-02-17 |
2006-08-24 |
Schering Ag |
Verwendung von CDKII Inhibitoren zur Fertilitätskontrolle
|
AU2006219643A1
(en)
|
2005-03-01 |
2006-09-08 |
Pfizer Limited |
Use of PDE7 inhibitors for the treatment of neuropathic pain
|
US7297700B2
(en)
|
2005-03-24 |
2007-11-20 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
US8859495B2
(en)
|
2005-03-30 |
2014-10-14 |
Minerva Biotechnologies Corporation |
Methods for stimulating or enhancing proliferation of non-tumorous cells expressing MUC1 receptors
|
JP2006284843A
(ja)
|
2005-03-31 |
2006-10-19 |
Mitsui Chemicals Inc |
テトラカルボン酸誘導体を用いた電子写真感光体、電子写真装置
|
US20060223993A1
(en)
|
2005-04-01 |
2006-10-05 |
Connor Daniel M |
Colorant compounds, intermediates, and compositions
|
JP2006316054A
(ja)
|
2005-04-15 |
2006-11-24 |
Tanabe Seiyaku Co Ltd |
高コンダクタンス型カルシウム感受性kチャネル開口薬
|
KR100781704B1
(ko)
|
2005-04-20 |
2007-12-03 |
에스케이케미칼주식회사 |
피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물
|
WO2006119504A2
(en)
|
2005-05-04 |
2006-11-09 |
Renovis, Inc. |
Fused heterocyclic compounds, and compositions and uses thereof
|
DK2161336T4
(en)
|
2005-05-09 |
2017-04-24 |
Ono Pharmaceutical Co |
Human monoclonal antibodies for programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapies
|
WO2006124731A2
(en)
*
|
2005-05-12 |
2006-11-23 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
US8183248B2
(en)
|
2005-05-13 |
2012-05-22 |
Irm Llc |
Substituted pyrrolo[2,3-d]pyrimidines and compositions as protein kinase inhibitors
|
US20060279115A1
(en)
|
2005-06-09 |
2006-12-14 |
Ash Tisdelle |
Vehicular head and neck safety system and method
|
GB0512844D0
(en)
|
2005-06-23 |
2005-08-03 |
Novartis Ag |
Organic compounds
|
AU2006265108C1
(en)
|
2005-07-01 |
2013-01-17 |
E. R. Squibb & Sons, L.L.C. |
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
|
EP1915377A1
(en)
|
2005-07-22 |
2008-04-30 |
Sunesis Pharmaceuticals, Inc. |
Pyrazolo pyrimidines useful as aurora kinase inhibitors
|
ES2270715B1
(es)
|
2005-07-29 |
2008-04-01 |
Laboratorios Almirall S.A. |
Nuevos derivados de pirazina.
|
US20100216798A1
(en)
|
2005-07-29 |
2010-08-26 |
Astellas Pharma Inc |
Fused heterocycles as lck inhibitors
|
RU2008108898A
(ru)
|
2005-08-09 |
2009-09-20 |
Айрм Ллк (Bm) |
Соединения и композиции в качестве ингибиторов протеинкиназы
|
AU2006279536A1
(en)
|
2005-08-16 |
2007-02-22 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
KR101011958B1
(ko)
|
2005-08-25 |
2011-01-31 |
에프. 호프만-라 로슈 아게 |
p38 MAP 키나아제 저해제로서의 융합형 피라졸
|
US7678917B2
(en)
|
2005-09-01 |
2010-03-16 |
Hoffman-La Roche Inc. |
Factor Xa inhibitors
|
CN101304986A
(zh)
|
2005-09-06 |
2008-11-12 |
史密丝克莱恩比彻姆公司 |
制备苯并咪唑噻吩类的区域选择性方法
|
AU2006289838B2
(en)
|
2005-09-15 |
2011-08-18 |
Aska Pharmaceutical Co., Ltd. |
Heterocyclic compound, and production process and use thereof
|
US20070116984A1
(en)
|
2005-09-21 |
2007-05-24 |
Doosan Corporation |
Spiro-compound for electroluminescent display device and electroluminescent display device comprising the same
|
US7482360B2
(en)
|
2005-09-23 |
2009-01-27 |
Schering Corporation |
Fused tetracyclic mGluR1 antagonists as therapeutic agents
|
DE102005048072A1
(de)
|
2005-09-24 |
2007-04-05 |
Bayer Cropscience Ag |
Thiazole als Fungizide
|
US7989622B2
(en)
|
2005-10-07 |
2011-08-02 |
Exelixis, Inc. |
Phosphatidylinositol 3-kinase inhibitors and methods of their use
|
CN102746298A
(zh)
|
2005-10-07 |
2012-10-24 |
埃克塞里艾克西斯公司 |
PI3Kα的吡啶并嘧啶酮抑制剂
|
WO2007061554A2
(en)
|
2005-10-21 |
2007-05-31 |
Purdue Research Foundation |
Dosage of 4-aminopyridine derivatives for treatment of central nervous system injuries
|
BRPI0617891A2
(pt)
|
2005-10-26 |
2011-08-09 |
Boehringer Ingelheim Int |
compostos de (hetero)arila com atividade antagonista de mch, sais fisiologicamente aceitáveis dos mesmos, composição, composição farmacêutica bem como uso e preparação dos ditos compostos
|
US8067457B2
(en)
|
2005-11-01 |
2011-11-29 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of CCR2
|
NZ592990A
(en)
|
2005-11-01 |
2013-01-25 |
Targegen Inc |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
WO2007056075A2
(en)
|
2005-11-02 |
2007-05-18 |
Targegen, Inc. |
Six membered heteroaromatic inhibitors targeting resistant kinase mutations
|
WO2007056170A2
(en)
|
2005-11-02 |
2007-05-18 |
Bayer Healthcare Ag |
Pyrrolo[2,1-f] [1,2,4] triazin-4-ylamines igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
|
WO2007059108A2
(en)
|
2005-11-10 |
2007-05-24 |
Chemocentryx, Inc. |
Substituted quinolones and methods of use
|
JP4371164B2
(ja)
|
2005-11-10 |
2009-11-25 |
萬有製薬株式会社 |
アザ置換スピロ誘導体
|
WO2007058626A1
(en)
|
2005-11-16 |
2007-05-24 |
S*Bio Pte Ltd |
Indazole compounds
|
AR057986A1
(es)
|
2005-11-21 |
2008-01-09 |
Japan Tobacco Inc |
Compuesto heterociclico y su uso farmaceutico
|
PE20070855A1
(es)
|
2005-12-02 |
2007-10-14 |
Bayer Pharmaceuticals Corp |
Derivados de 4-amino-pirrolotriazina sustituida como inhibidores de quinasas
|
MX2008007103A
(es)
|
2005-12-02 |
2008-09-12 |
Bayer Healthcare Llc |
Derivados 4-amino-pirrolotriazina sustituidos, útiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogenesis.
|
RU2008127486A
(ru)
|
2005-12-08 |
2010-01-20 |
Милленниум Фармасьютикалз, Инк. (Us) |
Бициклические соединения с ингибиторной активностью в отношении киназы
|
WO2007066189A2
(en)
|
2005-12-09 |
2007-06-14 |
Pfizer Products Inc. |
Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea
|
WO2007120339A1
(en)
|
2005-12-19 |
2007-10-25 |
Genentech, Inc. |
Pyrimidine kinase inhibitors
|
SMP200800041B
(it)
|
2005-12-21 |
2009-07-14 |
Novartis Ag |
Derivati di pirimidinil-aril-urea attivi come-fgf-inibitori
|
US7998959B2
(en)
|
2006-01-12 |
2011-08-16 |
Incyte Corporation |
Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
|
UY30118A1
(es)
|
2006-01-31 |
2007-06-29 |
Tanabe Seiyaku Co |
Compueto amina trisustituido
|
WO2007092879A2
(en)
|
2006-02-08 |
2007-08-16 |
Janssen Pharmaceutica, N.V. |
Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
|
ES2374455T3
(es)
|
2006-02-17 |
2012-02-16 |
Pfizer Limited |
Derivados de 3-deazapurinza como moduladores de tlr7.
|
WO2007109334A2
(en)
|
2006-03-21 |
2007-09-27 |
Epix Delaware, Inc. |
Sip receptor modulating compounds and use thereof
|
WO2008117269A2
(en)
|
2007-03-28 |
2008-10-02 |
Atir Holding S.A. |
Heterotri cyciii c compounds as serotonergic and/or dopaminergic agents and uses thereof
|
CA2680789C
(en)
|
2006-03-28 |
2016-02-16 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US20100273776A1
(en)
|
2006-03-29 |
2010-10-28 |
FOLDRx PHARMACEUTICALS, INC |
Inhibition of alpha-synuclein toxicity
|
JP2010505739A
(ja)
|
2006-04-06 |
2010-02-25 |
ウイスコンシン アラムニ リサーチ ファンデーション |
2−メチレン−1α,25−ジヒドロキシ−19,21−ジノルビタミンD3類縁体およびその使用
|
JP2009533426A
(ja)
|
2006-04-13 |
2009-09-17 |
アストラゼネカ・アクチエボラーグ |
チオキサンチン誘導体およびそれらのmpo阻害剤としての用途
|
GB0608386D0
(en)
|
2006-04-27 |
2006-06-07 |
Senexis Ltd |
Compounds
|
WO2007125405A2
(en)
|
2006-05-01 |
2007-11-08 |
Pfizer Products Inc. |
Substituted 2-amino-fused heterocyclic compounds
|
EP2027123B1
(en)
|
2006-05-11 |
2011-02-23 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
CN101460175A
(zh)
|
2006-05-15 |
2009-06-17 |
Irm责任有限公司 |
用于fgf受体激酶抑制剂的组合物和方法
|
US7910108B2
(en)
|
2006-06-05 |
2011-03-22 |
Incyte Corporation |
Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases
|
DE102006027156A1
(de)
|
2006-06-08 |
2007-12-13 |
Bayer Schering Pharma Ag |
Sulfimide als Proteinkinaseinhibitoren
|
WO2007147217A1
(en)
|
2006-06-22 |
2007-12-27 |
Prana Biotechnology Limited |
Method of treatment of glioma brain tumour
|
UY30444A1
(es)
|
2006-06-30 |
2008-01-31 |
Astrazeneca Ab |
Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos.
|
US20090281115A1
(en)
|
2006-06-30 |
2009-11-12 |
Board of Regents, The University of Texas System, a Texas University |
Inhibitors of c-kit and uses thereof
|
WO2008003766A2
(en)
|
2006-07-06 |
2008-01-10 |
Boehringer Ingelheim International Gmbh |
4-heter0cycl0alkylpyri(mi)dines, process for the preparation thereof and their use as medicaments
|
WO2008008234A1
(en)
|
2006-07-07 |
2008-01-17 |
Targegen, Inc. |
2-amino-5-substituted pyrimidine inhibitors
|
TW200811134A
(en)
|
2006-07-12 |
2008-03-01 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
WO2008012635A2
(en)
|
2006-07-26 |
2008-01-31 |
Pfizer Products Inc. |
Amine derivatives useful as anticancer agents
|
WO2008021851A2
(en)
|
2006-08-09 |
2008-02-21 |
Smithkline Beecham Corporation |
Novel compounds as antagonists or inverse agonists for opioid receptors
|
JP2010500994A
(ja)
|
2006-08-16 |
2010-01-14 |
エグゼリクシス, インコーポレイテッド |
Pi3kおよびmekモジュレーターを使用する方法
|
DE102006041382A1
(de)
|
2006-08-29 |
2008-03-20 |
Bayer Schering Pharma Ag |
Carbamoyl-Sulfoximide als Proteinkinaseinhibitoren
|
CA2974246C
(en)
|
2006-09-01 |
2020-02-25 |
Senhwa Biosciences, Inc. |
Tricyclic heteroaryl compounds and their use as protein modulators
|
AU2007338601C1
(en)
|
2006-09-05 |
2014-07-24 |
Emory University |
Tyrosine kinase inhibitors for prevention or treatment of infection
|
EP2270200A3
(en)
|
2006-09-11 |
2011-07-13 |
CGI Pharmaceuticals, Inc. |
Kinase inhibitors, and methods of using and identifying kinase inhibitors
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
US7858587B2
(en)
|
2006-09-21 |
2010-12-28 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted difluorobenzyl-benzene derivates, medicaments containing such compounds, their use and process for their manufacture
|
DE602007011645D1
(de)
|
2006-09-22 |
2011-02-10 |
Glaxo Group Ltd |
Pyrroloä2, 3-büpyridin-4-yl-benzolsulfonamidverbindungen als ikk2-hemmer
|
US20100029636A1
(en)
|
2006-09-28 |
2010-02-04 |
Peter Buehlmayer |
Lck inhibitors
|
MX2009003456A
(es)
|
2006-10-02 |
2009-04-14 |
Irm Llc |
Compuestos y composiciones como inhibidores de proteina cinasa.
|
US20100009956A1
(en)
|
2006-10-30 |
2010-01-14 |
Glaxo Group Limited , a corporation |
Novel substituted pyrimidines as cysteine protease inhibitors
|
US7858645B2
(en)
|
2006-11-01 |
2010-12-28 |
Hoffmann-La Roche Inc. |
Indazole derivatives
|
CN101600714B
(zh)
|
2006-11-10 |
2013-08-21 |
百时美施贵宝公司 |
吡咯并吡啶激酶抑制剂
|
WO2008063609A2
(en)
|
2006-11-17 |
2008-05-29 |
Polyera Corporation |
Diimide-based semiconductor materials and methods of preparing and using the same
|
WO2008063583A1
(en)
|
2006-11-17 |
2008-05-29 |
Polyera Corporation |
Acene-based organic semiconductor materials and methods of preparing and using the same
|
KR20080045536A
(ko)
|
2006-11-20 |
2008-05-23 |
에스케이케미칼주식회사 |
피리딘 화합물을 포함하는 간염 치료 및 예방 또는 간 보호효능을 갖는 약제 조성물
|
SI3034075T1
(sl)
|
2006-11-22 |
2018-12-31 |
Incyte Holdings Corporation |
Imidazotriazini in imidazopirimidini kot inhibitorji kinaze
|
CA2672828A1
(en)
|
2006-12-13 |
2008-06-26 |
Schering Corporation |
Methods of treatment
|
WO2008071455A1
(en)
|
2006-12-15 |
2008-06-19 |
Bayer Schering Pharma Aktiengesellschaft |
Bicyclic acyltryptophanols
|
WO2008074068A1
(en)
|
2006-12-20 |
2008-06-26 |
Prana Biotechnology Limited |
Substituted quinoline derivatives as antiamyloidogeneic agents
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
WO2008079933A2
(en)
|
2006-12-22 |
2008-07-03 |
Novartis Ag |
Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections
|
PL2121687T3
(pl)
|
2006-12-22 |
2016-03-31 |
Astex Therapeutics Ltd |
Pochodne amin tricyklicznych jako inhibitory białkowej kinazy tyrozynowej
|
JP5442448B2
(ja)
|
2006-12-22 |
2014-03-12 |
アステックス、セラピューティックス、リミテッド |
Fgfrインヒビターとしての二環式ヘテロ環式化合物
|
FR2911140B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
CN101622253B
(zh)
|
2007-01-08 |
2015-04-29 |
破立纪元有限公司 |
用于制备基于芳烃-双(二羧酰亚胺)的半导体材料的方法和用于制备它们的相关中间体
|
CN101007778A
(zh)
|
2007-01-10 |
2007-08-01 |
复旦大学 |
一种链延长型芴基双马来酰亚胺及其制备方法
|
US20100105661A1
(en)
|
2007-01-12 |
2010-04-29 |
Astellas Pharma Inc. |
Condensed pyridine compound
|
EP2535345A1
(en)
|
2007-01-12 |
2012-12-19 |
BioCryst Pharmaceuticals, Inc. |
Anticancer nucleoside analogs
|
FR2911604B1
(fr)
|
2007-01-19 |
2009-04-17 |
Sanofi Aventis Sa |
Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
|
JP5358962B2
(ja)
|
2007-02-06 |
2013-12-04 |
住友化学株式会社 |
組成物及び該組成物を用いてなる発光素子
|
JP2008198769A
(ja)
|
2007-02-13 |
2008-08-28 |
Nippon Steel Chem Co Ltd |
有機エレクトロルミネッセント素子
|
EA200901167A1
(ru)
|
2007-03-06 |
2010-04-30 |
Новартис Аг |
Бициклические органические соединения, пригодные для лечения воспалительных и аллергических состояний
|
MX2009009541A
(es)
|
2007-03-07 |
2009-09-16 |
Alantos Pharm Holding |
Inhibidores de metaloproteasa que contienen una porcion heterociclica.
|
KR20150043565A
(ko)
|
2007-03-12 |
2015-04-22 |
와이엠 바이오사이언시즈 오스트레일리아 피티와이 엘티디 |
페닐 아미노 피리미딘 화합물 및 이의 용도
|
US20080234262A1
(en)
|
2007-03-21 |
2008-09-25 |
Wyeth |
Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors
|
CA2680783C
(en)
|
2007-03-23 |
2012-04-24 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
KR20080091948A
(ko)
|
2007-04-10 |
2008-10-15 |
에스케이케미칼주식회사 |
락탐형 피리딘 화합물을 포함하는 허혈성 질환의 예방 및치료용 약학조성물
|
US20100112211A1
(en)
|
2007-04-12 |
2010-05-06 |
Advanced Technology Materials, Inc. |
Zirconium, hafnium, titanium, and silicon precursors for ald/cvd
|
JP2010524941A
(ja)
|
2007-04-20 |
2010-07-22 |
シェーリング コーポレイション |
ピリミジノン誘導体およびそれらの使用方法
|
EP1985612A1
(en)
|
2007-04-26 |
2008-10-29 |
Bayer Schering Pharma Aktiengesellschaft |
Arymethylen substituted N-Acyl-gamma-aminoalcohols
|
EP1990342A1
(en)
|
2007-05-10 |
2008-11-12 |
AEterna Zentaris GmbH |
Pyridopyrazine Derivatives, Process of Manufacturing and Uses thereof
|
PE20090288A1
(es)
|
2007-05-10 |
2009-04-03 |
Smithkline Beecham Corp |
Derivados de quinoxalina como inhibidores de la pi3 quinasa
|
WO2008144253A1
(en)
|
2007-05-14 |
2008-11-27 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
GB2449293A
(en)
|
2007-05-17 |
2008-11-19 |
Evotec |
Compounds having Hsp90 inhibitory activity
|
BRPI0812363A2
(pt)
|
2007-06-03 |
2015-02-03 |
Univ Vanderbilt |
Moduladores alostéricos positivos de mglurs de benzamida e métodos de preparação e utilização dos mesmos
|
US8163752B2
(en)
|
2007-06-07 |
2012-04-24 |
Merck, Sharp & Dohme Corp. |
Tricyclic anilide heterocyclic CGRP receptor antagonists
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
RU2010101052A
(ru)
|
2007-06-15 |
2011-07-20 |
Банью Фармасьютикал Ко., Лтд (Jp) |
Производные бициклоанилина
|
CA2855098C
(en)
|
2007-06-18 |
2018-02-27 |
Merck Sharp & Dohme B.V. |
Antibodies to human programmed death receptor pd-1
|
EP2183027B1
(en)
|
2007-07-26 |
2011-08-31 |
Novartis AG |
Organic compounds
|
EP2018859A1
(en)
|
2007-07-26 |
2009-01-28 |
Bayer Schering Pharma Aktiengesellschaft |
Arylmethylene substituted N-acyl-beta-amino alcohols
|
EP2020404A1
(en)
|
2007-08-01 |
2009-02-04 |
Bayer Schering Pharma Aktiengesellschaft |
Cyanomethyl substituted N-Acyl Tryptamines
|
EP2173354A4
(en)
|
2007-08-09 |
2011-10-05 |
Glaxosmithkline Llc |
CHINOXALIN DERIVATIVES AS PI3 KINASE INHIBITORS
|
WO2009019518A1
(en)
|
2007-08-09 |
2009-02-12 |
Astrazeneca Ab |
Pyrimidine compounds having a fgfr inhibitory effect
|
US9493419B2
(en)
|
2007-08-21 |
2016-11-15 |
The Hong Kong Polytechnic University |
Quinoline derivatives as anti-cancer agents
|
US7960400B2
(en)
|
2007-08-27 |
2011-06-14 |
Duquesne University Of The Holy Ghost |
Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
|
WO2009029625A1
(en)
|
2007-08-27 |
2009-03-05 |
Kalypsys, Inc. |
4- [heterocyclyl-methyl] -8-fluoro-quinolin-2-ones useful as nitric oxide synthase inhibitors
|
PT2200436E
(pt)
|
2007-09-04 |
2015-04-29 |
Scripps Research Inst |
Pirimidinilaminas substituídas como inibidoras da proteína quinase
|
WO2009030871A1
(en)
|
2007-09-07 |
2009-03-12 |
Vernalis R & D Ltd |
Pyrrolopyrimidine derivatives having hsp90 inhibitory activity
|
TW200920357A
(en)
|
2007-09-10 |
2009-05-16 |
Curis Inc |
HSP90 inhibitors containing a zinc binding moiety
|
BRPI0817527A2
(pt)
|
2007-10-01 |
2017-05-02 |
Isis Pharmaceuticals Inc |
modulação antissenso da expressão do receptor de fator de crescimento de fibroblasto humano 4
|
ES2549084T3
(es)
|
2007-10-05 |
2015-10-22 |
Msd K.K. |
Derivados de benzoxazinona
|
WO2009047255A1
(en)
|
2007-10-09 |
2009-04-16 |
Ucb Pharma, S.A. |
Heterobicyclic compounds as histamine h4-receptor antagonists
|
WO2009049018A1
(en)
|
2007-10-10 |
2009-04-16 |
Syndax Pharmaceuticals, Inc. |
Novel compounds and methods of using them
|
WO2009046606A1
(en)
|
2007-10-11 |
2009-04-16 |
Shanghai Institute Of Materia Medica, Cas |
Pyrimidinyl-propionic acid derivatives and their use as ppar agonists
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
WO2009047993A1
(ja)
|
2007-10-13 |
2009-04-16 |
Konica Minolta Holdings, Inc. |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
CN101883774A
(zh)
|
2007-10-16 |
2010-11-10 |
惠氏有限责任公司 |
噻吩并嘧啶和吡唑并嘧啶化合物及其用作mtor激酶和pi3激酶抑制剂的用途
|
PL2212323T3
(pl)
|
2007-10-17 |
2013-01-31 |
Novartis Ag |
Pochodne imidazo[1,2-a]pirydyny użyteczne jako inhibitory ALK
|
JP2011500778A
(ja)
|
2007-10-25 |
2011-01-06 |
アストラゼネカ・アクチエボラーグ |
ピリジン及びピラジン誘導体−083
|
RU2007139634A
(ru)
|
2007-10-25 |
2009-04-27 |
Сергей Олегович Бачурин (RU) |
Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения
|
WO2009056886A1
(en)
|
2007-11-01 |
2009-05-07 |
Astrazeneca Ab |
Pyrimidine derivatives and their use as modulators of fgfr activity
|
AU2008331867B2
(en)
|
2007-11-28 |
2014-05-22 |
Dana-Farber Cancer Institute, Inc. |
Small molecule myristate inhibitors of Bcr-abl and methods of use
|
US8461147B2
(en)
|
2007-12-03 |
2013-06-11 |
Boehringer Ingelheim International Gmbh |
Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
|
WO2009085185A1
(en)
|
2007-12-19 |
2009-07-09 |
Amgen Inc. |
Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
|
US8642660B2
(en)
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
EP2235019A1
(en)
|
2007-12-21 |
2010-10-06 |
Wyeth LLC |
Imidazo [1,2-b] pyridazine compounds as modulators of liver x receptors
|
WO2009086509A2
(en)
|
2007-12-27 |
2009-07-09 |
Purdue Research Foundation |
Reagents for biomolecular labeling, detection and quantification employing raman spectroscopy
|
FR2926297B1
(fr)
|
2008-01-10 |
2013-03-08 |
Centre Nat Rech Scient |
Molecules chimiques inhibitrices du mecanisme d'epissage pour traiter des maladies resultant d'anomalies d'epissage.
|
KR20100119776A
(ko)
|
2008-01-24 |
2010-11-10 |
알라 캠, 엘엘씨 |
2-알킬아미노-3-아릴설포닐-사이클로알카노[e 또는 d]피라졸로[1,5-A]피리미딘/세로토닌 5-HT6 수용체의 길항제, 이의 제조방법 및 이의 용도
|
JP5584627B2
(ja)
|
2008-01-24 |
2014-09-03 |
アンドレイ・アレクサンドロビッチ・イワシェンコ |
置換されたシクロアルキル[e又はd]ピラゾロ[1,5−a]ピリミジン−セロトニン5−HT6受容体のアンタゴニスト、その調製の方法及び使用
|
KR20100121629A
(ko)
|
2008-01-24 |
2010-11-18 |
유씨비 파마, 에스.에이. |
시클로부톡시 기를 포함하는 화합물
|
KR101709141B1
(ko)
|
2008-01-25 |
2017-02-22 |
브이티브이 테라퓨틱스 엘엘씨 |
TNF-α 합성의 조절자 및 PDE4 억제제로서 3고리 화합물
|
CN101981037B
(zh)
|
2008-01-30 |
2013-09-04 |
吉宁特有限公司 |
吡唑并嘧啶pi3k抑制剂化合物及使用方法
|
JP2011511005A
(ja)
|
2008-02-04 |
2011-04-07 |
オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド |
2−アミノピリジン系キナーゼ阻害薬
|
AU2009216851B2
(en)
|
2008-02-22 |
2013-11-07 |
F. Hoffmann-La Roche Ag |
Modulators for amyloid beta
|
BRPI0907591A2
(pt)
|
2008-02-22 |
2015-07-21 |
Irm Llc |
Compostos e composição farmacêutica como moduladores de atividade de gpr119, método in vitro para modulação da atividade de gpr119 e usos do referido composto, seus sais farmaceuticamente aceitáveis ou suas composições farmacêuticas.
|
US8383629B2
(en)
|
2008-02-27 |
2013-02-26 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11β-hydroxysteroid dehydrogenase type 1
|
WO2009108827A1
(en)
|
2008-02-29 |
2009-09-03 |
Wyeth |
Fused tricyclic pyrazolo[1, 5-a]pyrimidines, methods for preparation and uses thereof
|
ITTV20080039A1
(it)
|
2008-03-06 |
2009-09-07 |
Alpinestars Research Srl |
Collare di protezione in particolare per guidatori di motoveicoli
|
EP2262837A4
(en)
|
2008-03-12 |
2011-04-06 |
Merck Sharp & Dohme |
PD-1 BINDING PROTEINS
|
GB0804701D0
(en)
|
2008-03-13 |
2008-04-16 |
Amura Therapeutics Ltd |
Compounds
|
US8637542B2
(en)
|
2008-03-14 |
2014-01-28 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
WO2009114874A2
(en)
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Benzothiazole kinase inhibitors and methods of use
|
US20090246198A1
(en)
|
2008-03-31 |
2009-10-01 |
Takeda Pharmaceutical Company Limited |
Mapk/erk kinase inhibitors and methods of use thereof
|
US20100056524A1
(en)
|
2008-04-02 |
2010-03-04 |
Mciver Edward Giles |
Compound
|
US8436005B2
(en)
|
2008-04-03 |
2013-05-07 |
Abbott Laboratories |
Macrocyclic pyrimidine derivatives
|
WO2009126584A1
(en)
|
2008-04-07 |
2009-10-15 |
Amgen Inc. |
Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
|
WO2009124755A1
(en)
|
2008-04-08 |
2009-10-15 |
European Molecular Biology Laboratory (Embl) |
Compounds with novel medical uses and method of identifying such compounds
|
WO2009125808A1
(ja)
|
2008-04-11 |
2009-10-15 |
第一三共株式会社 |
アミノシクロヘキシル誘導体
|
WO2009125809A1
(ja)
|
2008-04-11 |
2009-10-15 |
第一三共株式会社 |
ピペリジン誘導体
|
EP2444403A1
(en)
|
2008-04-18 |
2012-04-25 |
Shionogi Co., Ltd. |
Heterocyclic compound having inhibitory activity on PI3K
|
EP2271631B1
(en)
|
2008-04-22 |
2018-07-04 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
US8309577B2
(en)
|
2008-04-23 |
2012-11-13 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
|
US7863291B2
(en)
|
2008-04-23 |
2011-01-04 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
CA2719868A1
(en)
|
2008-04-29 |
2009-11-05 |
F. Hoffmann-La Roche Ag |
Pyrimidinyl pyridone inhibitors of jnk.
|
CA2720888A1
(en)
|
2008-04-29 |
2009-11-05 |
Novartis Ag |
Methods of monitoring the modulation of the kinase activity of fibroblast growth factor receptor and uses of said methods
|
AR071523A1
(es)
|
2008-04-30 |
2010-06-23 |
Merck Serono Sa |
Compuestos biciclicos fusionados, un proceso para su preparacion, el compuesto para ser utilizado como medicamento en el tratamiento y profilaxis de enfermedades, una composicion farmaceutica y un conjunto que comprende paquetes separados del compuesto y de un ingrediente activo del medicamento
|
US9315449B2
(en)
|
2008-05-15 |
2016-04-19 |
Duke University |
Substituted pyrazoles as heat shock transcription factor activators
|
CA2725185C
(en)
|
2008-05-23 |
2016-10-25 |
Novartis Ag |
Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
|
WO2009144205A1
(en)
|
2008-05-30 |
2009-12-03 |
Basf Se |
Rylene-based semiconductor materials and methods of preparation and use thereof
|
US8207169B2
(en)
|
2008-06-03 |
2012-06-26 |
Msd K.K. |
Substituted [1,2,4]triazolo[4′,3′:1,6]pyrido[2,3-b]pyrazines of the formula D
|
KR101656793B1
(ko)
|
2008-06-10 |
2016-09-12 |
유디씨 아일랜드 리미티드 |
신규한 전이 금속 착물 및 이의 유기 발광 다이오드에서의 용도 - ⅲ
|
FR2932600B1
(fr)
|
2008-06-11 |
2010-06-04 |
Areva Np |
Embout inferieur d'assemblage de combustible nucleaire
|
WO2009151997A1
(en)
|
2008-06-12 |
2009-12-17 |
Merck & Co., Inc. |
Process for producing bicycloaniline derivatives
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
JP2011524888A
(ja)
|
2008-06-19 |
2011-09-08 |
アストラゼネカ アクチボラグ |
ピラゾール化合物436
|
JPWO2009157423A1
(ja)
|
2008-06-24 |
2011-12-15 |
財団法人乙卯研究所 |
縮合環を有するオキサゾリジノン誘導体
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
EP2303881A2
(en)
|
2008-07-14 |
2011-04-06 |
Gilead Sciences, Inc. |
Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases
|
WO2010007099A1
(en)
|
2008-07-15 |
2010-01-21 |
Cellzome Limited |
2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors
|
ES2552681T3
(es)
|
2008-07-15 |
2015-12-01 |
F. Hoffmann-La Roche Ag |
Nuevas fenil-imidazopiridinas y piridazinas
|
EP2328897A1
(en)
|
2008-07-16 |
2011-06-08 |
Schering Corporation |
Bicyclic heterocycle derivatives and their use as gpcr modulators
|
EP2318404B1
(en)
|
2008-07-16 |
2013-08-21 |
Merck Sharp & Dohme Corp. |
Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
|
UY31982A
(es)
|
2008-07-16 |
2010-02-26 |
Boehringer Ingelheim Int |
Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
|
US10722562B2
(en)
|
2008-07-23 |
2020-07-28 |
Immudex Aps |
Combinatorial analysis and repair
|
WO2010017047A1
(en)
|
2008-08-05 |
2010-02-11 |
Merck & Co., Inc. |
Therapeutic compounds
|
AR072906A1
(es)
|
2008-08-06 |
2010-09-29 |
Novartis Ag |
Nucleosidos modificados utiles como antivirales
|
CA2737219C
(en)
|
2008-08-11 |
2017-02-28 |
Tracy Keller |
Halofuginone analogs for inhibition of trna synthetases and uses thereof
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
WO2010030027A1
(en)
|
2008-09-10 |
2010-03-18 |
Mitsubishi Tanabe Pharma Corporation |
Aromatic nitrogen-containing 6-membered ring compounds and their use
|
EP3530672B1
(en)
|
2008-09-26 |
2024-05-01 |
Dana-Farber Cancer Institute, Inc. |
Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses thereof
|
WO2010038081A2
(en)
|
2008-10-03 |
2010-04-08 |
Astrazeneca Ab |
Heterocyclic derivatives and methods of use thereof
|
US20100267748A1
(en)
|
2008-10-15 |
2010-10-21 |
Gilead Palo Alto, Inc. |
HETEROCYCLIC COMPOUNDS USEFUL AS STEAROYL CoA DESATURASE INHIBITORS
|
US8110578B2
(en)
|
2008-10-27 |
2012-02-07 |
Signal Pharmaceuticals, Llc |
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
|
TW201022262A
(en)
|
2008-10-29 |
2010-06-16 |
Astrazeneca Ab |
Novel compounds 515
|
US8476282B2
(en)
|
2008-11-03 |
2013-07-02 |
Intellikine Llc |
Benzoxazole kinase inhibitors and methods of use
|
WO2010052448A2
(en)
|
2008-11-05 |
2010-05-14 |
Ucb Pharma S.A. |
Fused pyrazine derivatives as kinase inhibitors
|
WO2010059552A1
(en)
|
2008-11-18 |
2010-05-27 |
Glaxosmithkline Llc |
Prolyl hydroxylase inhibitors
|
UY32251A
(es)
|
2008-11-20 |
2010-05-31 |
Glaxosmithkline Llc |
Compuestos quimicos
|
WO2010064621A1
(ja)
|
2008-12-03 |
2010-06-10 |
コニカミノルタホールディングス株式会社 |
有機エレクトロルミネッセンス素子、有機エレクトロルミネッセンス素子材料、表示装置及び照明装置
|
KR101061599B1
(ko)
|
2008-12-05 |
2011-09-02 |
한국과학기술연구원 |
비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
|
JP5752601B2
(ja)
|
2008-12-08 |
2015-07-22 |
ブイエム ファーマ エルエルシー |
タンパク質受容体チロシンキナーゼ阻害薬の組成物
|
US8110265B2
(en)
|
2008-12-09 |
2012-02-07 |
The Coca-Cola Company |
Pet container and compositions having enhanced mechanical properties and gas barrier properties
|
SG10201708690SA
(en)
|
2008-12-09 |
2017-12-28 |
Genentech Inc |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
EP2376494A4
(en)
|
2008-12-12 |
2012-07-11 |
Msd Kk |
DIHYDROPYRIMIDOPIRYMIDINE DERIVATIVES
|
CA2745970A1
(en)
|
2008-12-12 |
2010-06-17 |
Msd K.K. |
Dihydropyrimidopyrimidine derivative
|
ES2544452T3
(es)
|
2008-12-19 |
2015-08-31 |
Genentech, Inc. |
Compuestos heterocíclicos y métodos de uso
|
JO2885B1
(en)
|
2008-12-22 |
2015-03-15 |
ايلي ليلي اند كومباني |
Protein kinase inhibitors
|
WO2010078427A1
(en)
|
2008-12-30 |
2010-07-08 |
Arqule, Inc. |
Substituted pyrazolo [3, 4-b] pyridine compounds
|
WO2010078421A1
(en)
|
2008-12-30 |
2010-07-08 |
Arqule, Inc. |
Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds
|
JP5908728B2
(ja)
|
2009-01-06 |
2016-04-26 |
ダナ ファーバー キャンサー インスティテュート インコーポレイテッド |
ピリミド−ジアゼピノンキナーゼ骨格化合物及び疾患を治療する方法
|
JOP20190231A1
(ar)
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
WO2010083145A1
(en)
|
2009-01-16 |
2010-07-22 |
Merck Sharp & Dohme Corp. |
IMIDAZO[1,2-a]PYRIDINES AND IMIDAZO[1,2-b]PYRIDAZINES AS MARK INHIBITORS
|
DE102009007038A1
(de)
|
2009-02-02 |
2010-08-05 |
Merck Patent Gmbh |
Metallkomplexe
|
JP2010180147A
(ja)
|
2009-02-04 |
2010-08-19 |
Mitsubishi Gas Chemical Co Inc |
シアン酸エステル化合物、およびその硬化物
|
ES2629337T3
(es)
|
2009-02-09 |
2017-08-08 |
Inserm - Institut National De La Santé Et De La Recherche Médicale |
Anticuerpos contra PD-1 y anticuerpos contra PD-L1 y usos de los mismos
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
TW201035102A
(en)
|
2009-03-04 |
2010-10-01 |
Gruenethal Gmbh |
Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
|
WO2010103306A1
(en)
|
2009-03-10 |
2010-09-16 |
Astrazeneca Uk Limited |
Benzimidazole derivatives and their use as antivaral agents
|
JP5615261B2
(ja)
|
2009-03-11 |
2014-10-29 |
学校法人関西学院 |
多環芳香族化合物
|
WO2010107765A1
(en)
|
2009-03-18 |
2010-09-23 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
|
EP2411057B1
(en)
|
2009-03-23 |
2020-05-06 |
Eli Lilly and Company |
Imaging agents for detecting neurological disorders
|
WO2010111573A1
(en)
|
2009-03-27 |
2010-09-30 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
WO2010117425A1
(en)
|
2009-03-31 |
2010-10-14 |
Biogen Idec Ma Inc. |
Certain substituted pyrimidines, pharmaceutical compositions thereof, and methods for their use
|
ES2465971T3
(es)
|
2009-04-06 |
2014-06-09 |
University Health Network |
Inhibidores de quinasa y método para tratar cáncer con los mismos
|
US8415378B2
(en)
|
2009-04-07 |
2013-04-09 |
Astrazeneca Ab |
Isoxazol-3(2H)-one analogs as therapeutic agents
|
GB0906472D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
GB0906470D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
JP5531446B2
(ja)
|
2009-04-20 |
2014-06-25 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、有機エレクトロルミネッセンス素子材料、表示装置および照明装置
|
ES2347630B1
(es)
|
2009-04-29 |
2011-09-08 |
Universitat Ramon Llull |
Sintesis y usos de 4-cianopentanoatos y 4-cianopentenoatos sustituidos.
|
US8765754B2
(en)
|
2009-04-29 |
2014-07-01 |
Locus Pharmaceuticals, Inc. |
Pyrrolotriazine compounds
|
WO2010127212A1
(en)
|
2009-04-30 |
2010-11-04 |
Forest Laboratories Holdings Limited |
Inhibitors of acetyl-coa carboxylase
|
JO2860B1
(en)
|
2009-05-07 |
2015-03-15 |
ايلي ليلي اند كومباني |
Phenylendazolyl compounds
|
JP5600891B2
(ja)
|
2009-05-15 |
2014-10-08 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置および照明装置
|
JP5604808B2
(ja)
|
2009-05-20 |
2014-10-15 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
JP5629980B2
(ja)
|
2009-05-22 |
2014-11-26 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
JP5568889B2
(ja)
|
2009-05-22 |
2014-08-13 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置、照明装置及び有機エレクトロルミネッセンス素子材料
|
JP5499519B2
(ja)
|
2009-05-27 |
2014-05-21 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
WO2010136031A1
(en)
|
2009-05-27 |
2010-12-02 |
Københavns Universitet |
Fibroblast growth factor receptor-derived peptides binding to ncam
|
GB0910003D0
(en)
|
2009-06-11 |
2009-07-22 |
Univ Leuven Kath |
Novel compounds for the treatment of neurodegenerative diseases
|
JP5600894B2
(ja)
|
2009-06-24 |
2014-10-08 |
コニカミノルタ株式会社 |
白色有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
JP5733841B2
(ja)
|
2009-06-25 |
2015-06-10 |
アルカーメス ファーマ アイルランド リミテッド |
神経学的および精神的障害の治療のための複素環式化合物
|
US8883888B2
(en)
|
2009-06-30 |
2014-11-11 |
Zeon Corporation |
Diarylamine compounds, aging inhibitor, polymer composition, crosslinked rubber product and molded article of the crosslinked product, and method of producing diarylamine compound
|
WO2011007819A1
(ja)
|
2009-07-17 |
2011-01-20 |
塩野義製薬株式会社 |
ラクタムまたはベンゼンスルホンアミド化合物を含有する医薬
|
WO2011011597A1
(en)
|
2009-07-24 |
2011-01-27 |
Duke University |
Prochelators useful for inhibiting metal-associated toxicity
|
FR2948568B1
(fr)
|
2009-07-30 |
2012-08-24 |
Sanofi Aventis |
Formulation pharmaceutique
|
TWI468402B
(zh)
|
2009-07-31 |
2015-01-11 |
必治妥美雅史谷比公司 |
降低β-類澱粉生成之化合物
|
JP2013501008A
(ja)
|
2009-08-05 |
2013-01-10 |
バーシテック リミテッド |
抗ウイルス性化合物ならびにそれを含む医薬組成物
|
JP2012197231A
(ja)
|
2009-08-06 |
2012-10-18 |
Oncotherapy Science Ltd |
Ttk阻害作用を有するピリジンおよびピリミジン誘導体
|
ES2561659T3
(es)
|
2009-08-07 |
2016-02-29 |
Chugai Seiyaku Kabushiki Kaisha |
Derivados de aminopirazol
|
WO2011018894A1
(en)
|
2009-08-10 |
2011-02-17 |
Raqualia Pharma Inc. |
Pyrrolopyrimidine derivatives as potassium channel modulators
|
EA026693B1
(ru)
|
2009-08-17 |
2017-05-31 |
Интелликайн ЭлЭлСи |
Производные бензоксазола и бензотиазола в качестве ингибиторов pi3-киназы
|
JP5577650B2
(ja)
|
2009-08-24 |
2014-08-27 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、有機エレクトロルミネッセンス素子材料、表示装置及び照明装置
|
KR101184115B1
(ko)
|
2009-08-31 |
2012-09-18 |
일동제약주식회사 |
신규 펩티드 데포르밀라제 저해제 화합물 및 그 제조방법
|
BR112012004533B1
(pt)
|
2009-09-03 |
2021-11-09 |
Bioenergenix |
Composto, composição farmacêutica, e uso do composto
|
JP5728683B2
(ja)
|
2009-09-04 |
2015-06-03 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH |
チロシンスレオニンキナーゼ阻害剤としての置換アミノキノキサリン
|
WO2011031740A1
(en)
|
2009-09-09 |
2011-03-17 |
Achaogen, Inc. |
Antibacterial fluoroquinolone analogs
|
EP2475666A2
(en)
|
2009-09-11 |
2012-07-18 |
Trius Therapeutics, Inc. |
Gyrase inhibitors
|
WO2011035376A1
(en)
|
2009-09-24 |
2011-03-31 |
Romar Engineering Pty Ltd |
A mould or mould core and a method of manufacturing a mould or mould core
|
WO2011041143A1
(en)
|
2009-10-01 |
2011-04-07 |
Merck Sharp & Dohme Corp. |
HETEROCYCLIC-FUSED PYRAZOLO[4,3-c]PYRIDIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
|
US8466155B2
(en)
|
2009-10-02 |
2013-06-18 |
Boehringer Ingelheim International Gmbh |
Pyrimidines
|
GB0917571D0
(en)
|
2009-10-07 |
2009-11-25 |
Karobio Ab |
Novel estrogen receptor ligands
|
EP2308866A1
(de)
|
2009-10-09 |
2011-04-13 |
Bayer CropScience AG |
Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
|
FR2951172B1
(fr)
|
2009-10-13 |
2014-09-26 |
Pf Medicament |
Derives pyrazolopyridines en tant qu'agent anticancereux
|
WO2011049987A2
(en)
|
2009-10-20 |
2011-04-28 |
Eiger Biopharmaceuticals, Inc. |
Azaindazoles to treat flaviviridae virus infection
|
KR20110043270A
(ko)
|
2009-10-21 |
2011-04-27 |
(주)씨에스엘쏠라 |
유기발광화합물 및 이를 구비한 유기발광소자
|
US8962652B2
(en)
|
2009-10-22 |
2015-02-24 |
Gilead Sciences, Inc. |
Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
EP2493472B1
(en)
|
2009-10-26 |
2016-12-07 |
Signal Pharmaceuticals, LLC |
Methods of synthesis and purification of heteroaryl compounds
|
IN2012DN03180A
(lt)
|
2009-10-30 |
2015-09-25 |
Novartis Ag |
|
KR20110049217A
(ko)
|
2009-11-04 |
2011-05-12 |
다우어드밴스드디스플레이머티리얼 유한회사 |
신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계 발광 소자
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
NZ599866A
(en)
|
2009-11-06 |
2014-09-26 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
MX2012005332A
(es)
|
2009-11-13 |
2012-10-15 |
Oscotec Inc |
Inhibidores de cinasa.
|
WO2011063159A1
(en)
|
2009-11-18 |
2011-05-26 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
JP2013032290A
(ja)
|
2009-11-20 |
2013-02-14 |
Dainippon Sumitomo Pharma Co Ltd |
新規縮合ピリミジン誘導体
|
US20120232073A1
(en)
|
2009-11-23 |
2012-09-13 |
Santhosh Francis Neelamkavil |
Fused bicyclic pyrimidine derivatives and methods of use thereof
|
US20130017199A1
(en)
|
2009-11-24 |
2013-01-17 |
AMPLIMMUNE ,Inc. a corporation |
Simultaneous inhibition of pd-l1/pd-l2
|
EP2332939A1
(en)
|
2009-11-26 |
2011-06-15 |
Æterna Zentaris GmbH |
Novel Naphthyridine derivatives and the use thereof as kinase inhibitors
|
NZ599938A
(en)
|
2009-12-01 |
2014-08-29 |
Abbvie Inc |
Novel tricyclic compounds
|
JP2011116840A
(ja)
|
2009-12-02 |
2011-06-16 |
Fujifilm Corp |
顔料微粒子分散体、これを用いた光硬化性組成物及びカラーフィルタ
|
AR079257A1
(es)
|
2009-12-07 |
2012-01-04 |
Novartis Ag |
Formas cristalinas de 3-(2,6-dicloro-3-5-dimetoxi-fenil)-1-{6-[4-(4-etil-piperazin-1-il)-fenil-amino]-pirimidin-4-il}-1-metil-urea y sales de las mismas
|
CN102858767B
(zh)
|
2009-12-17 |
2015-08-19 |
默沙东公司 |
作为syk抑制剂的氨基嘧啶
|
JP2013514986A
(ja)
|
2009-12-18 |
2013-05-02 |
ノバルティス アーゲー |
血液癌の処置方法
|
AU2010341573B2
(en)
|
2009-12-22 |
2016-10-13 |
Vertex Pharmaceuticals Incorporated |
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
|
FR2954315B1
(fr)
|
2009-12-23 |
2012-02-24 |
Galderma Res & Dev |
Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
|
FR2954317B1
(fr)
|
2009-12-23 |
2012-01-27 |
Galderma Res & Dev |
Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
|
US20110207736A1
(en)
|
2009-12-23 |
2011-08-25 |
Gatekeeper Pharmaceuticals, Inc. |
Compounds that modulate egfr activity and methods for treating or preventing conditions therewith
|
US20130096115A1
(en)
|
2009-12-28 |
2013-04-18 |
Afraxis, Inc. |
Methods for treating autism
|
EP2519523A1
(en)
|
2009-12-29 |
2012-11-07 |
Polyera Corporation |
Thionated aromatic bisimides as organic semiconductors and devices incorporating them
|
US9180127B2
(en)
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
WO2011080755A1
(en)
|
2009-12-29 |
2011-07-07 |
Advinus Therapeutics Private Limited |
Fused nitrogen heterocyclic compounds, process of preparation and uses thereof
|
WO2011082267A2
(en)
|
2009-12-30 |
2011-07-07 |
Arqule, Inc. |
Substituted triazolo-pyrazine compounds
|
AU2010339444A1
(en)
|
2009-12-30 |
2012-07-19 |
Arqule, Inc. |
Substituted pyrrolo-aminopyrimidine compounds
|
US8563567B2
(en)
|
2009-12-30 |
2013-10-22 |
Arqule, Inc. |
Substituted heterocyclic compounds
|
CN102115026A
(zh)
|
2009-12-31 |
2011-07-06 |
清华大学 |
一维纳米结构、其制备方法及一维纳米结构作标记的方法
|
US20130022629A1
(en)
|
2010-01-04 |
2013-01-24 |
Sharpe Arlene H |
Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof
|
WO2011082488A1
(en)
|
2010-01-06 |
2011-07-14 |
British Columbia Cancer Agency Branch |
Bisphenol derivative therapeutics and methods for their use
|
KR101483215B1
(ko)
|
2010-01-29 |
2015-01-16 |
한미약품 주식회사 |
단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
WO2011097717A1
(en)
|
2010-02-15 |
2011-08-18 |
University Of Victoria Innovation And Development Corporation |
Synthesis of bicyclic compounds and method for their use as therapeutic agents
|
MX2012009561A
(es)
|
2010-02-17 |
2012-11-23 |
Amgen Inc |
Carboxamidas como inhibidores de canales de sodio dependientes del voltaje.
|
SA111320200B1
(ar)
|
2010-02-17 |
2014-02-16 |
ديبيوفارم اس ايه |
مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة
|
US9193728B2
(en)
|
2010-02-18 |
2015-11-24 |
Medivation Technologies, Inc. |
Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
|
CN103740434B
(zh)
|
2010-02-18 |
2016-02-03 |
Ntn株式会社 |
增稠剂、润滑脂及它们的制造方法以及润滑脂封入轴承
|
EP2536410B1
(en)
|
2010-02-18 |
2015-09-23 |
Merck Sharp & Dohme Corp. |
Substituted pyrimidine derivatives and their use in treating viral infections
|
UY33227A
(es)
|
2010-02-19 |
2011-09-30 |
Novartis Ag |
Compuestos de pirrolopirimidina como inhibidores de la cdk4/6
|
US9403769B2
(en)
|
2010-02-22 |
2016-08-02 |
Advanced Cancer Therapeutics, Llc |
Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeutics
|
EP2541635B1
(en)
|
2010-02-26 |
2018-12-12 |
Nippon Steel & Sumikin Chemical Co., Ltd. |
Organic electroluminescent element
|
WO2011109237A2
(en)
|
2010-03-02 |
2011-09-09 |
Emory University |
Uses of noscapine and derivatives in subjects diagnosed with fap
|
WO2011111880A1
(ko)
|
2010-03-08 |
2011-09-15 |
주식회사 메디젠텍 |
세포핵에서 세포질로의 gsk3의 이동을 억제하는 화합물을 함유하는 세포핵에서 세포질로의 gsk3 이동에 의해 발생되는 질환의 치료 또는 예방용 약학적 조성물
|
US20110237599A1
(en)
|
2010-03-10 |
2011-09-29 |
Kalypsys, Inc. |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
NZ602362A
(en)
|
2010-03-11 |
2014-11-28 |
Gilead Connecticut Inc |
Imidazopyridines syk inhibitors
|
AU2011227643A1
(en)
|
2010-03-16 |
2012-09-20 |
Dana-Farber Cancer Institute, Inc. |
Indazole compounds and their uses
|
JP6065183B2
(ja)
|
2010-03-24 |
2017-01-25 |
アミテック セラピューティック ソリューションズ,インク. |
キナーゼ阻害に役立つ複素環式化合物
|
JP5752232B2
(ja)
|
2010-03-31 |
2015-07-22 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
プロテインキナーゼ阻害剤としての置換ピロロトリアジン化合物
|
CN102153551B
(zh)
|
2010-04-02 |
2012-04-25 |
济南海乐医药技术开发有限公司 |
基于吲唑或氮杂吲唑的双芳基脲或硫脲类结构抗肿瘤药物
|
JP5724204B2
(ja)
|
2010-04-07 |
2015-05-27 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置、及び照明装置
|
CA2792278C
(en)
|
2010-04-13 |
2019-05-14 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds and prodrugs thereof and their uses
|
PL2558095T3
(pl)
|
2010-04-16 |
2019-06-28 |
Novartis Ag |
Związek organiczny, przeznaczony do stosowania w leczeniu raka wątroby
|
JP2013525370A
(ja)
|
2010-04-22 |
2013-06-20 |
ヤンセン ファーマシューティカ エヌ.ベー. |
ケトヘキソキナーゼ阻害剤として有用なインダゾール化合物
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
CA2812043A1
(en)
|
2010-04-23 |
2011-10-27 |
Kineta, Inc. |
Pyrimidinedione anti-viral compounds
|
GB201007286D0
(en)
|
2010-04-30 |
2010-06-16 |
Astex Therapeutics Ltd |
New compounds
|
CN103025744A
(zh)
|
2010-04-30 |
2013-04-03 |
百时美施贵宝公司 |
作为α-7烟碱乙酰胆碱受体配体前药的氮杂二环胺N-氧化物化合物
|
US8759398B2
(en)
|
2010-05-03 |
2014-06-24 |
Biolink Life Sciences, Inc. |
Phosphorus binder composition for treatment of hyperphosphatemia
|
WO2011140338A1
(en)
|
2010-05-05 |
2011-11-10 |
Gatekeeper Pharmaceuticals, Inc. |
Compounds that modulate egfr activity and methods for treating or preventing conditions therewith
|
TWI513694B
(zh)
|
2010-05-11 |
2015-12-21 |
Amgen Inc |
抑制間變性淋巴瘤激酶的嘧啶化合物
|
JP2013528598A
(ja)
|
2010-05-11 |
2013-07-11 |
ファイザー・インク |
ミネラルコルチコイド受容体拮抗薬としてのモルホリン化合物
|
NZ603972A
(en)
|
2010-05-11 |
2014-11-28 |
Aveo Pharmaceuticals Inc |
Anti-fgfr2 antibodies
|
EP2569301A1
(en)
|
2010-05-12 |
2013-03-20 |
Abbvie Inc. |
Indazole inhibitors of kinase
|
US8961917B2
(en)
|
2010-05-12 |
2015-02-24 |
Spectrum Pharmaceuticals, Inc. |
Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
|
GB201008134D0
(en)
|
2010-05-14 |
2010-06-30 |
Medical Res Council Technology |
Compounds
|
WO2011147199A1
(en)
|
2010-05-28 |
2011-12-01 |
Versitech Limited |
Compounds and methods for treating viral infections
|
WO2011147198A1
(en)
|
2010-05-28 |
2011-12-01 |
Versitech Limited |
Compounds and methods for treatment of proliferative diseases
|
MX2012014158A
(es)
|
2010-06-04 |
2013-02-07 |
Hoffmann La Roche |
Derivados de aminopirimidina como moduladores de proteina cinasa rica repeticiones leucina 2 (lrrk2).
|
WO2011153553A2
(en)
|
2010-06-04 |
2011-12-08 |
The Regents Of The University Of California |
Methods and compositions for kinase inhibition
|
WO2011155983A1
(en)
|
2010-06-07 |
2011-12-15 |
Bikam Pharmaceuticals Inc. |
Opsin-binding ligands, compositions and methods of use
|
TW201210597A
(en)
|
2010-06-09 |
2012-03-16 |
Gilead Sciences Inc |
Inhibitors of hepatitis C virus
|
US8299117B2
(en)
|
2010-06-16 |
2012-10-30 |
Metabolex Inc. |
GPR120 receptor agonists and uses thereof
|
CA2802344C
(en)
|
2010-06-18 |
2023-06-13 |
The Brigham And Women's Hospital, Inc. |
Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditions
|
EP2584903B1
(en)
|
2010-06-24 |
2018-10-24 |
Merck Sharp & Dohme Corp. |
Novel heterocyclic compounds as erk inhibitors
|
US8907053B2
(en)
|
2010-06-25 |
2014-12-09 |
Aurigene Discovery Technologies Limited |
Immunosuppression modulating compounds
|
WO2012005744A1
(en)
|
2010-06-27 |
2012-01-12 |
King Saud University |
One-time password authentication with infinite nested hash claims
|
EP2588110B1
(en)
|
2010-07-02 |
2018-10-17 |
University Health Network |
Methods of targeting pten mutant diseases and compositions therefor
|
FR2962437B1
(fr)
|
2010-07-06 |
2012-08-17 |
Sanofi Aventis |
Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique
|
FR2962438B1
(fr)
|
2010-07-06 |
2012-08-17 |
Sanofi Aventis |
Derives d'indolizines, procedes de preparation et application en therapeutique
|
US20130109682A1
(en)
|
2010-07-06 |
2013-05-02 |
Novartis Ag |
Cyclic ether compounds useful as kinase inhibitors
|
DE102010031127A1
(de)
|
2010-07-08 |
2012-01-12 |
Endress + Hauser Flowtec Ag |
Messaufnehmer eines thermischen Durchflussmessgeräts zur Ermittlung des Durchflusses eines Mediums durch ein Messrohr und Verfahren zu dessen Herstellung
|
JP5810157B2
(ja)
|
2010-07-09 |
2015-11-11 |
ザ・ウォルター・アンド・エリザ・ホール・インスティテュート・オブ・メディカル・リサーチ |
プロテインキナーゼ阻害剤および処置の方法
|
WO2012009258A2
(en)
|
2010-07-13 |
2012-01-19 |
Edward Roberts |
Peptidomimetic galanin receptor modulators
|
WO2012008999A2
(en)
|
2010-07-14 |
2012-01-19 |
Merck Sharp & Dohme Corp. |
Tricyclic compounds as allosteric modulators of metabotropic glutamate receptors
|
TW201206946A
(en)
|
2010-07-15 |
2012-02-16 |
Bristol Myers Squibb Co |
Compounds for the reduction of beta-amyloid production
|
KR20130091331A
(ko)
|
2010-07-16 |
2013-08-16 |
교와 핫꼬 기린 가부시키가이샤 |
함질소 방향족 복소환 유도체
|
WO2012008564A1
(ja)
|
2010-07-16 |
2012-01-19 |
協和発酵キリン株式会社 |
含窒素芳香族複素環誘導体
|
CA2806655A1
(en)
|
2010-07-28 |
2012-02-02 |
Bayer Intellectual Property Gmbh |
Substituted imidazo[1,2-b]pyridazines
|
EP2413140A1
(en)
|
2010-07-29 |
2012-02-01 |
Sanofi |
Method for identifying a compound having an antiarrhythmic effect as well as uses relating thereto
|
CN103140564B
(zh)
|
2010-07-30 |
2015-11-25 |
罗门哈斯电子材料韩国有限公司 |
使用电致发光化合物作为发光材料的电致发光器件
|
WO2012019093A1
(en)
|
2010-08-05 |
2012-02-09 |
Human Biomolecular Research Institute |
Synthetic compounds and methods to decrease nicotine self-administration
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8883801B2
(en)
|
2010-08-23 |
2014-11-11 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
|
WO2012027239A1
(en)
|
2010-08-23 |
2012-03-01 |
Schering Corporation |
NOVEL PYRAZOLO[1,5-a]PYRROLO[3,2-e]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
|
WO2012030990A1
(en)
|
2010-09-01 |
2012-03-08 |
Gilead Connecticut, Inc. |
Pyridazinones, method of making, and method of use thereof
|
KR101837223B1
(ko)
|
2010-09-01 |
2018-03-09 |
질레드 코네티컷 인코포레이티드 |
피리디논/피라지논, 그의 제조 방법 및 사용 방법
|
ES2602972T3
(es)
|
2010-09-08 |
2017-02-23 |
Glaxosmithkline Intellectual Property Development Limited |
Derivados de indazol para su uso en el tratamiento de infección por virus de la gripe
|
PL2614058T3
(pl)
|
2010-09-08 |
2015-12-31 |
Glaxosmithkline Ip Dev Ltd |
Polimorfy i sole n-[5-[4-(5-{[(2r,6s)-2,6-dimetylo-4-morfolinylo]-metylo}-1,3-oksazol-2-ilo)-1h-indazol-6-ilo]-2-(metyloksy)-3-pirydynylo]metanosulfonamidu
|
AR082799A1
(es)
|
2010-09-08 |
2013-01-09 |
Ucb Pharma Sa |
Derivados de quinolina y quinoxalina como inhibidores de quinasa
|
TWI541243B
(zh)
|
2010-09-10 |
2016-07-11 |
拜耳知識產權公司 |
經取代咪唑并嗒
|
KR20130103503A
(ko)
|
2010-09-14 |
2013-09-23 |
호도가야 가가쿠 고교 가부시키가이샤 |
전하 제어제 및 그것을 사용한 토너
|
CN102399220A
(zh)
|
2010-09-15 |
2012-04-04 |
黄振华 |
三并环类PI3K和mTOR双重抑制剂
|
CN102399233B
(zh)
|
2010-09-15 |
2014-08-13 |
山东轩竹医药科技有限公司 |
PI3K和mTOR双重抑制剂类化合物
|
WO2012036233A1
(ja)
|
2010-09-17 |
2012-03-22 |
塩野義製薬株式会社 |
メラニン凝集ホルモン受容体アンタゴニスト活性を有する縮合へテロ環誘導体
|
GB201015949D0
(en)
|
2010-09-22 |
2010-11-03 |
Medical Res Council Technology |
Compounds
|
JO3062B1
(ar)
|
2010-10-05 |
2017-03-15 |
Lilly Co Eli |
R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
|
EP2629777B1
(en)
|
2010-10-22 |
2018-12-19 |
Merck Sharp & Dohme Corp. |
Bicyclic diamines as janus kinase inhibitors
|
EP2955183A1
(en)
|
2010-10-25 |
2015-12-16 |
G1 Therapeutics, Inc. |
Cdk inhibitors
|
JP2012092049A
(ja)
|
2010-10-27 |
2012-05-17 |
Sumitomo Chemical Co Ltd |
有害動物防除組成物及び有害動物の防除方法
|
CA2816022C
(en)
|
2010-10-29 |
2019-09-10 |
Emory University |
Quinazoline derivatives, compositions, and uses related thereto
|
WO2012061337A1
(en)
|
2010-11-02 |
2012-05-10 |
Exelixis, Inc. |
Fgfr2 modulators
|
CA2815179A1
(en)
|
2010-11-10 |
2012-05-18 |
Actelion Pharmaceuticals Ltd |
Lactam derivatives useful as orexin receptor antagonists
|
TW201305139A
(zh)
|
2010-11-10 |
2013-02-01 |
Gruenenthal Gmbh |
作為類香草素受體配體之經取代雜芳基甲醯胺及尿素衍生物
|
JP2012116825A
(ja)
|
2010-11-11 |
2012-06-21 |
Ehime Univ |
アセンジイミド化合物の製造方法
|
KR101171232B1
(ko)
|
2010-11-15 |
2012-08-06 |
단국대학교 산학협력단 |
스파이로 화합물 및 이를 포함하는 유기전계 발광소자
|
WO2012065297A1
(en)
|
2010-11-16 |
2012-05-24 |
Impact Therapeutics, Inc. |
3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
|
US8765768B2
(en)
|
2010-11-17 |
2014-07-01 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
AU2011330730B2
(en)
|
2010-11-18 |
2016-02-18 |
Kasina Laila Innova Pharmaceuticals Private Limited |
Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
|
GB201020179D0
(en)
|
2010-11-29 |
2011-01-12 |
Astex Therapeutics Ltd |
New compounds
|
EP2649065A1
(en)
|
2010-12-09 |
2013-10-16 |
Amgen Inc. |
Bicyclic compounds as pim inhibitors
|
US20140031547A1
(en)
|
2010-12-14 |
2014-01-30 |
Electrophoretics Limited |
CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
|
LT2655357T
(lt)
|
2010-12-20 |
2016-10-10 |
Merck Serono S.A. |
Indazolilo triazolo dariniai, kaip irak inhibitoriai
|
CN103402977B
(zh)
|
2010-12-22 |
2016-01-20 |
利奥实验室有限公司 |
巨大戟二萜醇-3-酰化物iii和巨大戟二萜醇-3-氨基甲酸酯
|
US8754114B2
(en)
|
2010-12-22 |
2014-06-17 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
|
EP2468258A1
(en)
|
2010-12-22 |
2012-06-27 |
LEK Pharmaceuticals d.d. |
Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
|
US9656945B2
(en)
|
2010-12-22 |
2017-05-23 |
Leo Laboratories Limited |
3-acyl-ingenols II
|
EP2655342A1
(en)
|
2010-12-23 |
2013-10-30 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
JP5691508B2
(ja)
|
2010-12-27 |
2015-04-01 |
Jnc株式会社 |
ジイミド化合物ならびにインクジェット用インクおよびその用途
|
KR101466150B1
(ko)
|
2010-12-31 |
2014-11-27 |
제일모직 주식회사 |
유기광전소자용 화합물 및 이를 포함하는 유기광전소자
|
EP2662378B1
(en)
|
2011-01-06 |
2018-10-10 |
JX Nippon Oil & Energy Corporation |
Imide compound, method for producing same, thickening agent for grease, and grease composition
|
US8362023B2
(en)
|
2011-01-19 |
2013-01-29 |
Hoffmann-La Roche Inc. |
Pyrazolo pyrimidines
|
FR2970967B1
(fr)
|
2011-01-27 |
2013-02-15 |
Pf Medicament |
Derives de type azaindazole ou diazaindazole comme medicament
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
WO2012112961A1
(en)
|
2011-02-18 |
2012-08-23 |
Medivation Technologies, Inc. |
Compounds and methods of treating hypertension
|
WO2012116237A2
(en)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
TWI532742B
(zh)
|
2011-02-28 |
2016-05-11 |
艾伯維有限公司 |
激酶之三環抑制劑
|
WO2012125812A1
(en)
|
2011-03-17 |
2012-09-20 |
Novartis Ag |
Fgfr and ligands thereof as biomarkers for breast cancer in hr positive subjects
|
MY161199A
(en)
|
2011-03-23 |
2017-04-14 |
Amgen Inc |
Fused tricyclic dual inhibitors of cdk 4/6 and flt3
|
ITPD20110091A1
(it)
|
2011-03-24 |
2012-09-25 |
Univ Padova |
Inibitori multitirosinchinasi utili per le patologie correlate: modelli farmacoforici, composti identificati tramite questi modelli, metodi per la loro preparazione, la loro formulazione e il loro impiego terapeutico.
|
CN103635458B
(zh)
|
2011-03-25 |
2016-10-19 |
艾伯维公司 |
Trpv1拮抗剂
|
RU2013143358A
(ru)
|
2011-04-07 |
2015-05-20 |
Дженентек, Инк. |
Анти-fgfr4 антитела и способы их применения
|
FR2974088A1
(fr)
|
2011-04-12 |
2012-10-19 |
Pf Medicament |
Composes pyrazolo[3,4-b]pyridines tri- et tetracycliques comme agent anticancereux
|
PE20140995A1
(es)
|
2011-05-16 |
2014-08-23 |
Genentech Inc |
Agonistas de fgfr1 y sus metodos de uso
|
WO2012158795A1
(en)
|
2011-05-17 |
2012-11-22 |
Principia Biopharma Inc. |
Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
|
CN103687858B
(zh)
|
2011-05-17 |
2017-11-21 |
拜耳知识产权有限责任公司 |
作为mknk1激酶抑制剂的氨基取代的咪唑并哒嗪
|
KR20140023358A
(ko)
|
2011-05-19 |
2014-02-26 |
노파르티스 아게 |
선양 낭성 암종의 치료에 사용하기 위한 4-아미노-5-플루오로-3-[6-(4-메틸피페라진-1-일)-1h-벤즈이미다졸-2-일]-1h-퀴놀린-2-온
|
CN103717604B
(zh)
|
2011-06-01 |
2016-06-01 |
拜耳知识产权有限责任公司 |
取代的氨基咪唑并哒嗪
|
TW201316991A
(zh)
|
2011-06-03 |
2013-05-01 |
Millennium Pharm Inc |
Mek抑制劑與奧諾拉(aurora)a激酶選擇性抑制劑之組合
|
WO2012173370A2
(ko)
|
2011-06-13 |
2012-12-20 |
주식회사 엘지화학 |
신규한 화합물 및 이를 이용한 유기 전자 소자
|
CN103764656A
(zh)
|
2011-06-22 |
2014-04-30 |
拜耳知识产权有限责任公司 |
杂环基氨基咪唑并哒嗪
|
US8846656B2
(en)
|
2011-07-22 |
2014-09-30 |
Novartis Ag |
Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators
|
CN105001226B
(zh)
|
2011-08-12 |
2017-09-08 |
日产化学工业株式会社 |
三环杂环化合物和jak抑制剂
|
CN103874700B
(zh)
|
2011-08-12 |
2018-03-30 |
霍夫曼-拉罗奇有限公司 |
吡唑并[3,4‑c]吡啶化合物和使用方法
|
JP2013049251A
(ja)
|
2011-08-31 |
2013-03-14 |
Fujifilm Corp |
レーザー彫刻用レリーフ印刷版原版、並びに、レリーフ印刷版及びその製版方法
|
WO2013033981A1
(zh)
|
2011-09-06 |
2013-03-14 |
江苏先声药物研究有限公司 |
一类2,7-萘啶衍生物及其制备方法和应用
|
US9345705B2
(en)
|
2011-09-15 |
2016-05-24 |
Merck Sharp & Dohme Corp. |
Compositions and methods for treating cancer
|
US9320737B2
(en)
|
2011-09-23 |
2016-04-26 |
Bayer Intellectual Property Gmbh |
Substituted imidazopyridazines
|
US9376435B2
(en)
|
2011-09-23 |
2016-06-28 |
Jawaharlal Nehru Centre For Advanced Scientific Research |
Chromophores for the detection of volatile organic compounds
|
JP2014528410A
(ja)
|
2011-09-30 |
2014-10-27 |
キネタ・インコーポレイテツド |
抗ウイルス化合物
|
UA111382C2
(uk)
|
2011-10-10 |
2016-04-25 |
Оріон Корпорейшн |
Інгібітори протеїнкінази
|
WO2013053051A1
(en)
|
2011-10-12 |
2013-04-18 |
University Health Network |
Indazole compounds as kinase inhibitors and method of treating cancer with same
|
KR101897044B1
(ko)
|
2011-10-20 |
2018-10-23 |
에스에프씨 주식회사 |
유기금속 화합물 및 이를 포함하는 유기전계발광소자
|
CA2853095A1
(en)
|
2011-10-28 |
2013-05-02 |
Novartis Ag |
Method of treating gastrointestinal stromal tumors
|
WO2013063003A1
(en)
|
2011-10-28 |
2013-05-02 |
Novartis Ag |
Method of treating gastrointestinal stromal tumors
|
WO2013088191A1
(en)
|
2011-12-12 |
2013-06-20 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3
|
WO2013088266A1
(en)
|
2011-12-13 |
2013-06-20 |
Ecolab Usa Inc. |
Concentrated warewashing compositions and methods
|
FR2985257B1
(fr)
|
2011-12-28 |
2014-02-14 |
Sanofi Sa |
Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique
|
FR2985258A1
(fr)
|
2011-12-28 |
2013-07-05 |
Sanofi Sa |
Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique
|
WO2013109027A1
(ko)
|
2012-01-18 |
2013-07-25 |
덕산하이메탈(주) |
화합물, 이를 이용한 유기전기소자 및 그 전자 장치
|
US10026905B2
(en)
|
2012-01-18 |
2018-07-17 |
Duk San Neolux Co., Ltd. |
Compound, organic electric element using the same, and an electronic device thereof
|
ES2516392T3
(es)
|
2012-01-19 |
2014-10-30 |
Taiho Pharmaceutical Co., Ltd. |
Compuesto de alquinilbenceno 3,5-disustituido y sal del mismo
|
US9475815B2
(en)
|
2012-02-23 |
2016-10-25 |
Bayer Intelletual Property Gmbh |
Substituted benzothienyl-pyrrolotriazines and uses thereof
|
JP2013179181A
(ja)
|
2012-02-28 |
2013-09-09 |
Sumitomo Chemical Co Ltd |
有機光電変換素子
|
CU24335B1
(es)
|
2012-03-14 |
2018-04-03 |
Lupin Ltd |
Piridopirimidinas sustituidas como inhibidores de la quinasa mek y útiles para el tratamiento del cáncer
|
CN104321058A
(zh)
|
2012-03-30 |
2015-01-28 |
诺华股份有限公司 |
用于治疗低磷血性疾病的fgfr抑制剂
|
JP5120580B1
(ja)
|
2012-05-14 |
2013-01-16 |
Jsr株式会社 |
液晶配向剤
|
LT2852354T
(lt)
|
2012-05-20 |
2020-09-25 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Mitralinio vožtuvo protezas
|
UA117347C2
(uk)
|
2012-06-13 |
2018-07-25 |
Інсайт Холдинґс Корпорейшн |
Заміщені трициклічні сполуки як інгібітори fgfr
|
CN109627239B
(zh)
|
2012-07-11 |
2021-10-12 |
缆图药品公司 |
成纤维细胞生长因子受体的抑制剂
|
US20150202203A1
(en)
|
2012-07-11 |
2015-07-23 |
Novartis Ag |
Method of Treating Gastrointestinal Stromal Tumors
|
JP2015525782A
(ja)
|
2012-08-02 |
2015-09-07 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
抗糖尿病性三環式化合物
|
WO2014019186A1
(en)
|
2012-08-02 |
2014-02-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
WO2014026125A1
(en)
|
2012-08-10 |
2014-02-13 |
Incyte Corporation |
Pyrazine derivatives as fgfr inhibitors
|
KR101985259B1
(ko)
|
2012-08-10 |
2019-06-03 |
제이에스알 가부시끼가이샤 |
액정 배향제 및 화합물
|
WO2014044846A1
(en)
|
2012-09-24 |
2014-03-27 |
Evotec (Uk) Ltd. |
3-(aryl- or heteroaryl-amino)-7-(3,5-dimethoxyphenyl)isoquinoline derivatives as fgfr inhibitors useful for the treatment of proliferative disorders or dysplasia
|
WO2014048878A1
(en)
|
2012-09-26 |
2014-04-03 |
Evotec (Uk) Ltd. |
Phenyl- or pyridyl- pyrrolo[2,3b]pyrazine derivatives useful in the treatment or prevention of proliferative disorders or dysplasia
|
WO2014062454A1
(en)
|
2012-10-15 |
2014-04-24 |
Merck Sharp & Dohme Corp. |
Compositions and methods for treating cancer
|
KR102000211B1
(ko)
|
2012-10-29 |
2019-09-30 |
삼성디스플레이 주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
US20140148548A1
(en)
|
2012-11-28 |
2014-05-29 |
Central Glass Company, Limited |
Fluorine-Containing Polymerizable Monomer And Polymer Compound Using Same
|
RU2660349C2
(ru)
|
2012-11-28 |
2018-07-05 |
Мерк Шарп И Доум Корп. |
Композиции и способы для лечения злокачественной опухоли
|
CN104968664A
(zh)
|
2012-12-12 |
2015-10-07 |
山东亨利医药科技有限责任公司 |
作为酪氨酸激酶抑制剂的并环化合物
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
TWI629266B
(zh)
|
2012-12-28 |
2018-07-11 |
藍印藥品公司 |
纖維母細胞生長因子受體之抑制劑
|
WO2014105849A1
(en)
|
2012-12-28 |
2014-07-03 |
Xoma (Us) Llc |
Antibodies specific for fgfr4 and methods of use
|
KR102030587B1
(ko)
|
2013-01-09 |
2019-10-10 |
에스에프씨주식회사 |
두 개의 나프틸기를 포함하는 비대칭 안트라센 유도체 및 이를 포함하는 유기 발광 소자
|
CN103588771B
(zh)
|
2013-01-15 |
2016-01-27 |
苏州云轩医药科技有限公司 |
具有刺猬通路拮抗剂活性的嘧啶类抗肿瘤化合物
|
EP2945623B1
(en)
|
2013-01-15 |
2018-09-05 |
Suzhou Kintor Pharmaceuticals, Inc. |
Hedgehog pathway signaling inhibitors and therapeutic applications thereof
|
KR101456626B1
(ko)
|
2013-02-01 |
2014-11-03 |
대영이앤비 주식회사 |
냉장고 부압 방지 장치
|
JP6311093B2
(ja)
|
2013-03-07 |
2018-04-18 |
国立大学法人九州大学 |
超分子複合体、発光体、および有機化合物検出用のセンサー素子
|
WO2014138485A1
(en)
|
2013-03-08 |
2014-09-12 |
Irm Llc |
Ex vivo production of platelets from hematopoietic stem cells and the product thereof
|
US9498532B2
(en)
|
2013-03-13 |
2016-11-22 |
Novartis Ag |
Antibody drug conjugates
|
WO2014160478A1
(en)
|
2013-03-13 |
2014-10-02 |
Flatley Discovery Lab |
Compounds and methods for the treatment of cystic fibrosis
|
WO2014140184A1
(en)
|
2013-03-14 |
2014-09-18 |
AbbVie Deutschland GmbH & Co. KG |
Novel inhibitor compounds of phosphodiesterase type 10a
|
AR095464A1
(es)
|
2013-03-15 |
2015-10-21 |
Celgene Avilomics Res Inc |
Compuestos de heteroarilo y usos de los mismos
|
EP3943087A1
(en)
|
2013-03-15 |
2022-01-26 |
Celgene CAR LLC |
Heteroaryl compounds and uses thereof
|
CN105307657B
(zh)
|
2013-03-15 |
2020-07-10 |
西建卡尔有限责任公司 |
杂芳基化合物和其用途
|
US9499522B2
(en)
|
2013-03-15 |
2016-11-22 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
TWI628176B
(zh)
|
2013-04-04 |
2018-07-01 |
奧利安公司 |
蛋白質激酶抑制劑
|
KR101573611B1
(ko)
|
2013-04-17 |
2015-12-01 |
주식회사 엘지화학 |
플러렌 유도체, 이를 이용한 유기 태양 전지 및 이의 제조 방법
|
CN105263931B
(zh)
|
2013-04-19 |
2019-01-25 |
因赛特公司 |
作为fgfr抑制剂的双环杂环
|
WO2014170063A1
(en)
|
2013-04-19 |
2014-10-23 |
Covagen Ag |
Novel bispecific binding molecules with antitumoral activity
|
GB201307577D0
(en)
|
2013-04-26 |
2013-06-12 |
Astex Therapeutics Ltd |
New compounds
|
WO2014182829A1
(en)
|
2013-05-09 |
2014-11-13 |
Principia Biopharma Inc. |
Quinolone derivatives as fibroblast growth factor inhibitors
|
JP2016521721A
(ja)
|
2013-06-14 |
2016-07-25 |
サノフイ |
膀胱がんの治療で使用するためのピラゾロピリジン誘導体
|
NZ716392A
(en)
|
2013-06-28 |
2017-03-31 |
Beigene Ltd |
Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors
|
WO2014206344A1
(en)
|
2013-06-28 |
2014-12-31 |
Beigene, Ltd. |
Fused tricyclic amide compounds as multiple kinase inhibitors
|
WO2015000715A1
(en)
|
2013-07-02 |
2015-01-08 |
Syngenta Participations Ag |
Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents
|
JP6018547B2
(ja)
|
2013-07-09 |
2016-11-02 |
大成ロテック株式会社 |
舗装機械
|
CA2917667A1
(en)
|
2013-07-09 |
2015-01-15 |
Dana-Farber Cancer Institute, Inc. |
Kinase inhibitors for the treatment of disease
|
CN117486865A
(zh)
|
2013-07-11 |
2024-02-02 |
艾森医药公司 |
嘧啶衍生物作为激酶抑制剂
|
AR097455A1
(es)
|
2013-08-28 |
2016-03-16 |
Astellas Pharma Inc |
Composición farmacéutica que contiene compuesto de pirimidina como un ingrediente activo
|
WO2015057938A1
(en)
|
2013-10-18 |
2015-04-23 |
Eisai R&D Management Co., Ltd. |
Pyrimidine fgfr4 inhibitors
|
AU2014338549B2
(en)
|
2013-10-25 |
2017-05-25 |
Novartis Ag |
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
|
EP3395814B1
(en)
|
2013-10-25 |
2022-04-06 |
Blueprint Medicines Corporation |
Inhibitors of the fibroblast growth factor receptor
|
FR3012330B1
(fr)
|
2013-10-29 |
2015-10-23 |
Oreal |
Composition biphase comprenant un ester d'acide gras et de sucre ou un alkylpolyglucoside liquide, de hlb < 8, et un alcane ramifie en c8-c18
|
WO2015066452A2
(en)
|
2013-11-01 |
2015-05-07 |
Foundation Medicine, Inc. |
Methods of treating pediatric cancers
|
US9695165B2
(en)
|
2014-01-15 |
2017-07-04 |
Blueprint Medicines Corporation |
Inhibitors of the fibroblast growth factor receptor
|
AU2015306561B2
(en)
|
2014-08-19 |
2018-03-15 |
Shanghai Haihe Pharmaceutical Co., Ltd. |
Indazole compounds as FGFR kinase inhibitor, preparation and use thereof
|
CN104262330B
(zh)
|
2014-08-27 |
2016-09-14 |
广东东阳光药业有限公司 |
一种脲取代联苯类化合物及其组合物及用途
|
JP6664385B2
(ja)
|
2014-09-19 |
2020-03-13 |
バイエル ファーマ アクチエンゲゼルシャフト |
Bub1阻害薬としてのベンジル置換インダゾール類
|
US20160115164A1
(en)
|
2014-10-22 |
2016-04-28 |
Incyte Corporation |
Bicyclic heterocycles as fgfr4 inhibitors
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
WO2016134294A1
(en)
|
2015-02-20 |
2016-08-25 |
Incyte Corporation |
Bicyclic heterocycles as fgfr4 inhibitors
|
PE20180021A1
(es)
|
2015-02-20 |
2018-01-09 |
Univ Oregon Health & Science |
Derivados de sobetiroma
|
UA121669C2
(uk)
|
2015-02-20 |
2020-07-10 |
Інсайт Корпорейшн |
Біциклічні гетероцикли як інгібітори fgfr
|
AU2016272089B2
(en)
|
2015-06-03 |
2021-02-18 |
Triastek, Inc. |
Dosage forms and use thereof
|
PE20180571A1
(es)
|
2015-07-15 |
2018-04-04 |
Protagonist Therapeutics Inc |
Inhibidores peptidicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias
|
KR20180026438A
(ko)
|
2015-07-15 |
2018-03-12 |
에프. 호프만-라 로슈 아게 |
대사형 글루타메이트 수용체 조절제로서의 에틴일 유도체
|
MY189596A
(en)
|
2015-07-15 |
2022-02-18 |
Immatics Biotechnologies Gmbh |
A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
|
CA2992267C
(en)
|
2015-07-15 |
2020-07-21 |
Cabot Corporation |
Methods of making an elastomer composite reinforced with silica and products containing same
|
KR20180093127A
(ko)
|
2015-07-30 |
2018-08-20 |
마크로제닉스, 인크. |
Pd-1-결합 분자 및 그것의 사용 방법
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10195185B2
(en)
|
2015-08-03 |
2019-02-05 |
Samumed, Llc |
3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017024025A1
(en)
|
2015-08-03 |
2017-02-09 |
Sunil Kumar Kc |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017023989A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017024003A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10329309B2
(en)
|
2015-08-03 |
2019-06-25 |
Samumed, Llc |
3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
EP3337787B1
(en)
|
2015-08-20 |
2021-03-03 |
JS InnoPharm (Shanghai) Ltd. |
1h-pyrazolo[3,4-b]pyridine, 1h-thieno[2,3-c]pyrazole and 1h-indazole carboxamide derivatives and related compounds as extracellular signal-regulated kinases (erk) inhibitors for treating cancer
|
EP3356349A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
EP3365340B1
(en)
|
2015-10-19 |
2022-08-10 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
AU2016341445B2
(en)
|
2015-10-23 |
2020-08-27 |
Array Biopharma, Inc. |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
|
MX2018006207A
(es)
|
2015-11-19 |
2018-09-05 |
Incyte Corp |
Compuestos heterociclicos como inmunomoduladores.
|
US20170174671A1
(en)
|
2015-12-17 |
2017-06-22 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
LT3394033T
(lt)
|
2015-12-22 |
2021-03-10 |
Incyte Corporation |
Heterocikliniai junginiai, kaip imunomoduliatoriai
|
TW201808950A
(zh)
|
2016-05-06 |
2018-03-16 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
US20170342060A1
(en)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
EP4137489A1
(en)
|
2016-06-20 |
2023-02-22 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
AR108875A1
(es)
|
2016-06-24 |
2018-10-03 |
Incyte Corp |
COMPUESTOS HETEROCÍCLICOS COMO INHIBIDORES DE PI3K-g
|
WO2018013789A1
(en)
|
2016-07-14 |
2018-01-18 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
MA46045A
(fr)
|
2016-08-29 |
2021-04-28 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
US10647693B2
(en)
|
2016-08-30 |
2020-05-12 |
North & South Brother Pharmacy Investment Company Limited |
Inhibitors of influenza virus replication, application methods and uses thereof
|
WO2018049214A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
|
EP3523306A4
(en)
|
2016-10-05 |
2020-05-06 |
Recurium IP Holdings, LLC |
SPIROCYCLIC COMPOUNDS
|
KR101755556B1
(ko)
|
2016-11-18 |
2017-07-07 |
주식회사 케마스 |
육산화사비소의 결정다형을 포함하는 뇌암 예방 또는 치료용 약학 조성물 및 이의 제조방법
|
KR101834366B1
(ko)
|
2016-11-21 |
2018-03-05 |
주식회사 케마스 |
육산화사비소의 결정다형을 포함하는 유방암 예방 또는 치료용 약학 조성물 및 이의 제조방법
|
KR101844049B1
(ko)
|
2016-12-05 |
2018-03-30 |
주식회사 케마스 |
육산화사비소의 결정다형을 포함하는 간암 예방 또는 치료용 약학 조성물
|
KR101844050B1
(ko)
|
2016-12-09 |
2018-05-14 |
주식회사 케마스 |
육산화사비소의 결정다형을 포함하는 암 예방 또는 치료용 약학 조성물
|
WO2018119263A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds derivatives as pd-l1 internalization inducers
|
HRP20221216T1
(hr)
|
2016-12-22 |
2022-12-23 |
Incyte Corporation |
Derivati tetrahidro imidazo[4,5-c]piridina kao induktori internalizacije pd-l1
|
MX2019007416A
(es)
|
2016-12-22 |
2019-12-11 |
Incyte Corp |
Derivados de benzooxazol como inmunomoduladores.
|
WO2018119221A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
US20180179202A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
US20180179201A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
WO2018234354A1
(en)
|
2017-06-20 |
2018-12-27 |
Grünenthal GmbH |
NOVEL SUBSTITUTED 3-INDOLE AND 3-INDAZOLE COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS
|
US11242334B2
(en)
|
2017-08-22 |
2022-02-08 |
Js Innopharm (Shanghai) Ltd. |
Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof
|
US10793551B2
(en)
|
2017-10-19 |
2020-10-06 |
Effector Therapeutics Inc. |
Benzimidazole-indole inhibitors of Mnk1 and Mnk2
|
EP3717471B1
(en)
|
2017-12-02 |
2022-01-05 |
Galapagos NV |
Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
|
CR20200520A
(es)
|
2018-03-30 |
2021-03-09 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
MA52493A
(fr)
|
2018-05-04 |
2021-03-10 |
Incyte Corp |
Sels d'un inhibiteur de fgfr
|
SG11202010636VA
(en)
|
2018-05-04 |
2020-11-27 |
Incyte Corp |
Solid forms of an fgfr inhibitor and processes for preparing the same
|
RS64188B1
(sr)
|
2018-05-11 |
2023-06-30 |
Incyte Corp |
Tetrahidro-imidazo[4,5-c]piridin derivati kao pd-l1 imunomodulatori
|
EP3836923A4
(en)
|
2018-08-14 |
2022-05-18 |
Osteoqc Inc. |
PYRROLO-DIPYRIDINE COMPOUNDS
|
WO2020049017A1
(en)
|
2018-09-07 |
2020-03-12 |
Merck Patent Gmbh |
5-morpholin-4-yl-pyrazolo[4,3-b]pyridine derivatives
|
WO2020081898A1
(en)
|
2018-10-20 |
2020-04-23 |
The Johns Hopkins University |
Non-invasive urinary biomarkers for the detection of urothelial carcinoma of the bladder
|
CN113474337A
(zh)
|
2018-12-19 |
2021-10-01 |
奥瑞生物药品公司 |
作为fgfr抑制剂用于治疗癌症的7-((3,5-二甲氧基苯基)氨基)喹喔啉衍生物
|
EP3898626A1
(en)
|
2018-12-19 |
2021-10-27 |
Array Biopharma, Inc. |
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of fgfr tyrosine kinases
|
US11628162B2
(en)
|
2019-03-08 |
2023-04-18 |
Incyte Corporation |
Methods of treating cancer with an FGFR inhibitor
|
WO2021007269A1
(en)
|
2019-07-09 |
2021-01-14 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
US20210094935A1
(en)
|
2019-10-01 |
2021-04-01 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
PE20221085A1
(es)
|
2019-10-14 |
2022-07-05 |
Incyte Corp |
Heterociclos biciclicos como inhibidores de fgfr
|
WO2021076728A1
(en)
|
2019-10-16 |
2021-04-22 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
WO2021113479A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
CN115151539A
(zh)
|
2019-12-04 |
2022-10-04 |
因赛特公司 |
Fgfr抑制剂的衍生物
|
WO2021146424A1
(en)
|
2020-01-15 |
2021-07-22 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
JP2024513575A
(ja)
|
2021-04-12 |
2024-03-26 |
インサイト・コーポレイション |
Fgfr阻害剤及びネクチン-4標的化剤を含む併用療法
|